Unravelling chromosomal instability in mammalian preimplantation embryos using single-cell genomics by Tšuiko, Olga
1
Tartu 2018
ISSN 1024-395X
ISBN 978-9949-77-861-4
O
LG
A
 TŠU
IK
O
 
U
nravelling chrom
osom
al instability in m
am
m
alian preim
plantation em
bryos using single-cell genom
ics
OLGA TŠUIKO
Unravelling chromosomal instability
in mammalian preimplantation embryos
using single-cell genomics
DISSERTATIONES 
MEDICINAE
UNIVERSITATIS 
TARTUENSIS
274
DISSERTATIONES MEDICINAE UNIVERSITATIS TARTUENSIS 
274 
 
 
 
  
DISSERTATIONES MEDICINAE UNIVERSITATIS TARTUENSIS 
274 
 
 
 
 
 
 
 
 
OLGA TŠUIKO 
 
 
Unravelling chromosomal instability  
in mammalian preimplantation embryos  
using single-cell genomics 
  
Institute of Biomedicine and Translational Medicine, University of Tartu, Estonia 
 
Dissertation is accepted for the commencement of the degree of Doctor of 
Philosophy in Medicine on August 22nd, 2018 by the Council of the Faculty of 
Medicine, University of Tartu, Estonia. 
 
Supervisor:  Professor Andres Salumets, PhD 
Department of Obstetrics and Gynaecology /  
 Institute of Biomedicine and Translational Medicine, 
 University of Tartu, Estonia 
Professor Joris Robert Vermeesch, PhD 
Laboratory for Cytogenetics and Genome Research /  
Center for Human Genetics, KU Leuven, Belgium 
Professor Ants Kurg, PhD 
Department of Biotechnology / Institute of Molecular and Cell 
Biology, University of Tartu, Estonia 
 
Reviewers:  Professor Alireza Fazeli, PhD 
Department of Pathophysiology / Institute of Biomedicine and 
Translational Medicine, University of Tartu, Estonia 
Dr. Martti Laan, PhD 
Department of Molecular Pathology / Institute of Biomedicine 
and Translational Medicine, University of Tartu, Estonia 
   
Opponent:  Professor Joyce Harper, PhD 
Department of Reproductive Health / Institute for Women’s 
Health / University College London, United Kingdom 
 
Commencement:  November 26, 2018 
 
 
 
 
 
ISSN 1024-395X 
ISBN 978-9949-77-861-4 (print) 
ISBN 978-9949-77-862-1 (pdf) 
 
Copyright: Olga Tšuiko, 2018 
 
 
University of Tartu Press 
www.tyk.ee 
 
 
 
 
 
 
 
 
 
  
 
Fundamentally, the embryo of a higher animal form 
Never resembles the adult of another animal form 
But only it’s embryo 
Karl Ernst von Baer  
“Über Entwickelungsgeschichte der Thiere“ 
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PROLOGUE 
“The decline of fertility is one of the most fundamental 
 social changes that happened in human history” 
Max Roser, creator of “Our World In Data” 
 
It seems ironic, even a little paradox, that with rapid world population growth 
voices started to emerge, raising concerns about the diminished fertility rates. 
This is especially evident in the developed countries that face the impending 
population decline. After the post-World War II baby boom, the birth rates 
started to decline in 1970s and this trend is persisting until today. According to 
the United Nations (U.N.) data for 2015, the global fertility rate has reached its 
unprecedented low levels, but differences in childbearing exist among various 
countries and regions. Low-fertility countries include all of Europe and Northern 
America, and many countries in Asia and Latin America and the Caribbean. In 
contrast, women in most of the countries in the sub-Saharan Africa, where child 
mortality rate is still high, have five or more children over their lifetime. Of 
course, social, cultural, economic and political climates are the key factors 
influencing birth figures. The fertility rate drop can also be attributed to the 
developing countries own efforts to control their rapidly expanding populations. 
One of the most significant population planning programs was initiated in 1979 
in China with the introduction of the One Child Policy, in which it was dis-
couraged to have more than one child. Notorious India compulsory sterilization 
program was also implemented for population control in 1976, a practice that is 
still being used in some regions of Bangladesh. Although the national fertility 
rate is still high in those countries, both India and Bangladesh have encountered 
a steady decline over the years of 2000s. In the Western world, technological 
progress, economic reforms, changing religious norms and family values, 
women’s empowerment and higher costs of childcare and education have all 
reflected in the declining fertility rate. In some countries, including Estonia, the 
average age at first pregnancy has reached 30 years of age. At the same time, 
the life expectancy continues to increase, creating a substantial imbalance in the 
ratio of elderly dependents to working-age people. The U.N. predicts that by 
2100 almost 30% of the population will consist of people >60 years, which may 
lead to fears of economic stagnation, if there will be not enough workers to 
support the elderly. As a result, a new two-child policy became effective from 
January 1, 2016 in China to address the aging issue, while the Western world 
countries offer substantial financial incentives and subsidies to encourage 
women to have children.  
The role of women in society has changed, giving them better education and 
increased employment opportunities. With more options for self-improvement 
and with increased cost of living in developed countries, women take the 
advantage of these opportunities and delay motherhood until later in life. But 
then there is another side to the story… 
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INTRODUCTION 
Women and men continue to delay parenthood worldwide due to various personal 
and socioeconomic reasons. As a consequence, involuntary childlessness and 
age-related infertility became a common medical problem, affecting 10–20% of 
couples of reproductive years. The increasing prevalence of infertility has led to 
an explosion in the use of assisted reproductive technologies (ART). The most 
commonly used ART technique is in vitro fertilization (IVF), where in vitro 
fertilized oocytes are cultured under artificial conditions and the developed 
embryos are transferred back to the uterus. Today, fertility treatment has 
become standard care in many countries and the field of assisted reproduction 
has progressed rapidly over the last decade. According to European statistics, 
almost half a million IVF cycles are performed annually, resulting in the birth of 
100,000 newborns, which account for up to 5% of all babies born in Europe. 
Despite scientific efforts, ART is still powerless to help many couples, as IVF 
success rate remains moderate with only 30% of patients getting pregnant per 
single treatment. The low efficiency of IVF poses significant social and finan-
cial burden to all patients that can result in emotional distress and feelings of 
stigmatization. Although IVF outcome depends on many clinical, demographic 
and lifestyle factors, genomic integrity of IVF embryos and the functional 
endometrium play the most crucial role. Hence, the wish to improve IVF treat-
ment has triggered great interest towards deeper understanding of human repro-
duction. 
Recent years have seen a plethora of technological breakthroughs, especially 
in the field of single-cell research. Owing to innovative single-cell approaches, 
it has become prominent that one of the inherent features of human IVF 
embryos is chromosomal instability (CIN), which is manifested by an increased 
rate of full chromosome aneuploidies, segmental deletions and duplications, 
uniparental disomies and translocations. These events in embryonic cells also 
contribute to chromosomal mosaicism that can be fatal to the embryo, causing 
developmental arrest, implantation failure, miscarriage or, in the worst case 
scenario, the birth of a child with chromosomal disorder. To tackle this issue, 
preimplantation genetic testing for aneuploidy (PGT-A) has been implemented 
into the clinics to detect embryonic aneuploidy and ensure uterine transfer of the 
most viable embryos. On the other hand, CIN can be seen as a driver of genomic 
evolution that may also occur in natural conceptions. The existence of embryonic 
CIN in natural reproduction is indirectly supported by the birth of mosaic and 
mixoploid/chimeric individuals.  
By using cutting-edge single-cell technologies, the current thesis addresses 
the topic of embryonic CIN with the general aim to expand our knowledge on 
the origin of genomic instability in preimplantation embryos. Given the ethical 
restrictions, associated with human embryo research, this work utilizes bovine as 
an animal model to investigate the nature of chromosomal instability during 
early development in vivo and in vitro. Additionally, we investigate the 
feasibility of newly advocated blastocoel fluid biopsy for PGT-A – a topic that 
has gained much controversial attention.  
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I. LITERATURE OVERVIEW 
1. Biology of reproduction:  
from oogenesis to embryogenesis 
1.1. Basics of oocyte development 
Oocyte is the largest cell in the human body that develops in the ovarian 
follicle, and it is large enough to be visible to the naked human eye without the 
aid of a microscope. Apart from providing half of the genetic material, the 
oocyte supplies the zygote with nearly all cytoplasmic and transcriptional factors 
necessary for successful early embryo development. One of the crucial aspects of 
oogenesis is the meiotic maturation of the oocyte, which is achieved through 
two sequential asymmetric cell divisions – meiosis I and meiosis II – that result 
in the formation of a fully functional haploid egg and two non-viable polar 
bodies. Yet, to achieve reproductive success, the oocyte must first gain 
developmental competence to resume meiosis, to become fertilized, to guide 
first post-zygotic cleavages and to maintain early embryonic survival (Sirard et 
al., 2006). Hence, the road to oocyte maturation goes through complex and 
carefully regulated stages of oogenesis in parallel with folliculogenesis that take 
their roots already in human prenatal development. It is generally accepted that 
the final number of oocytes and follicles is established during fetal period of life 
and no new germ cells are produced after birth, but this view has been 
challenged recently, suggesting that potential postnatal de novo oogenesis may 
exist (Johnson et al., 2004; Virant-Klun, 2015).  
The journey of oocyte development starts already in the fetal ovaries and is 
accompanied by a transition from mitosis to meiosis (Fig. 1). First, primordial 
germ cells differentiate into small immature diploid germ cells, called oogonia. 
Oogonia then undergo rapid mitotic proliferation from the second to seventh 
month of gestation period, forming roughly 7 million cells. Surprisingly, oocyte 
formation is an incredibly wasteful event, because it is accompanied by an 
extensive embryonic germ cell loss due to mitotic arrest and apoptosis, so only 
around 20% of the original cohort will remain by the time of birth (Hartshorne et 
al., 2009). Those oogonia that successfully enter meiosis will undergo meiotic 
recombination at prophase stage, forming primary oocytes. Primary oocytes do 
not complete the first meiotic division, but rather maintain a meiotic arrest in 
the protracted prophase stage, termed dictyate, until puberty. At this stage of 
development the nucleus of an oocyte is called germinal vesicle (GV), and the 
cell is embedded within the primordial follicle, surrounded by a single layer of 
flat pregranulosa cells (Fig. 1). Although GV oocytes remain in a prolonged 
resting phase, they are still transcriptionally active to assure a sufficient level of 
housekeeping functions (Susor et al., 2015). Primary oocytes that are not 
surrounded by somatic cells will undergo apoptosis, so once again a substantial 
amount of oocytes are lost by the time of puberty as only 300,000–400,000 
follicles remain.  
15 
 
Figure 1. Main stages of folliculogenesis and oocyte development. Oocyte 
maturation (top) is coupled with long process of ovarian follicle maturation (bottom). 
First, primordial germ cells (PGCs) rapidly proliferate and differentiate into oogonial 
stem cells, encapsulated in the germ cell cyst. As cysts break down, oogonia enter 
meiosis, forming primordial follicle. Upon initiation of folliculogenesis, primordial 
follicles become primary follicles with embedded immature oocyte that is in a 
prolonged resting phase of meiosis I, also known as germinal vesicle stage. Next, 
proliferating granulosa cells create several layers around the oocyte, forming secondary, 
early antral and finally preovulatory follicles with two distinct follicular somatic cell 
populations: cumulus cells (dark purple) and mural granulosa cells (light purple). Upon 
luteinizing hormone (LH) surge, only one dominant follicle ovulates, releasing the 
mature secondary oocyte, while other follicles will undergo follicular atresia. 
 
Upon puberty and onwards, primordial follicles are continuously activated by 
follicle-stimulating hormone (FSH) to initiate folliculogenesis and oocyte 
growth. Granulosa cells, surrounding the oocyte, start to proliferate to form first 
primary and then secondary follicles. The rise of estrogen levels, produced by 
the growing follicles, eventually triggers luteinizing hormone (LH) pre-
ovulatory surge that signals the oocyte to overcome dictyate arrest and proceed 
with meiosis: the germinal vesicle breaks down, the first meiotic division is 
accomplished and the meiotic cell cycle progresses until the oocyte reaches 
nuclear maturation and arrests again at metaphase of meiosis II, ready to be 
fertilized (Park et al., 2004). Apart from chromosome reduction and haploidi-
zation, the newly formed secondary oocyte acquires cytoplasmic maturation that 
involves translational and post-translational protein modifications, as well as 
organellar structural and functional changes essential to support early stages of 
embryo development [reviewed in (Coticchio et al., 2015)]. Hence, the zygote 
will inherit maternal factors to meet the demands of a cleaving embryo until 
maternal-to-zygotic transition (MZT). It is important to note that oocyte nuclear 
and cytoplasmic maturation is constantly supported by follicular somatic cells 
that provide nutrients and metabolites, like amino acids, lactate and pyruvate, 
which are used to generate ATP in mitochondria and maintain ion- and redox 
homeostasis in the growing oocyte (Collado-Fernandez et al., 2012). Granulosa/ 
cumulus cells also exchange many regulatory signals that control oocyte 
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metabolism, cytoskeletal remodeling, maintenance of meiotic arrest and sub-
sequent meiotic resumption – all of which are key events necessary for 
successful oocyte fertilization and support of early embryogenesis. In turn, 
oocyte-secreted factors contribute to granulosa cell differentiation and cumulus 
cell expansion (Hussein et al., 2005; Hussein et al., 2006; Diaz et al., 2007), so 
a carefully orchestrated cross-talk between the oocyte and the surrounding folli-
cular cells is essential for achievement of both oocyte competence and follicle 
maturation.  
Although a pool of primary oocytes/follicles is recruited each month during 
menstrual cycle, only a small fraction will reach maturity and ovulate, while the 
rest will undergo follicular death, or atresia. This continued gradual loss of germ 
cells drastically influences female reproductive capacity, as out of the initial 
thousands and thousands of cells only 300–400 develop into mature eggs during 
women’s reproductive lifespan. Finally, the depletion of ovarian reserves results 
in menopause and cessation of oogenesis (Faddy et al., 1992). Currently, it is 
not yet fully understood how the fate of germ cells is determined and whether 
the whole process follows the strict “survival of the fittest” rule or the selection 
of the oocytes to develop is purely stochastic. 
 
 
1.1.1. Molecular control of meiotic division in oocytes 
Meiosis is one of the defining milestones of human gametogenesis by which 
haploid gametes are generated from diploid precursors, following two spe-
cialized cell divisions, known as meiosis I (MI) and meiosis II (MII). Meiotic 
division is also called a reduction division that involves the disjunction of 
homologous chromosomes in MI, followed by segregation of sister chromatids 
during MII. Hence, genome integrity of germ cells strongly relies on intact 
cellular and molecular mechanisms involved in accurate chromosome 
segregation during meiotic progression. However, a number of sex-specific 
differences make female meiosis more complex. The most obvious difference 
occurs already at the late prophase of MI: male gametes proceed quickly 
through the first meiotic division, while oocytes encounter meiotic arrest that 
can last for decades. Second, unlike developing spermatocytes, oocytes lose 
their centrioles during meiotic prophase and subsequently segregate their 
chromosomes on an acentrosomal spindle (Manandhar et al., 2005). Instead, 
meiotic spindle is assembled by numerous acentriolar microtubule-organizing 
centers (aMTOCs), at least in mouse oocytes (Schuh and Ellenberg, 2007). 
These aMTOCs have similar microtubule nucleation properties as centrosomes, 
suggesting that they can substitute their function, leading to self-organization of 
the meiotic spindle. Whether human oocyte spindle assembly operates via 
similar mechanism is yet to be determined. Finally, male germ divisions are 
symmetric and produce four equally sized gametes, while eccentric positioning 
of oocyte meiotic spindle results in an asymmetric cell division that yields a 
large fertilizable egg and small non-functional structures known as the first and 
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second polar bodies (Brunet and Verlhac, 2011). Such asymmetric division also 
allows the oocyte to retain maximum of its cellular cytoplasm. 
Female meiosis I is preceded by a round of pre-meiotic DNA replication that 
forms pairs of homologous chromosomes (one paternal and one maternal), each 
containing two sister chromatids (Fig. 2). Before the onset of the first meiotic 
division, homologous chromosome pairs are initially zipped together by the 
synaptonemal complex protein structure and undergo reciprocal exchange of 
genetic material between homologous chromosomes via homologous recombi-
nation (HR). HR is initiated at DNA double-strand breaks (DSBs), generated 
across the genome by endonuclease SPO11 (Baudat et al., 2013). These DSBs 
recruit repair proteins that search for homologous chromosomes, promoting 
pairing and synapsis of homologs. DSB repair results in two outcomes: 
generation of crossovers that link homologs and generation of non-crossovers 
that result in gene conversion. The maturation of meiotic DSBs to crossovers is 
mediated by the DNA mismatch repair protein complex MLH1-MLH3 (Lenzi et 
al., 2005). The formation of crossovers has two essential purposes: (i) the 
exchange of genetic material at crossover sites promotes the genetic diversity in 
offspring, and (ii) the establishment of a physical linkage between homologs 
(chiasma) at the crossover sites ensures accurate homolog segregation upon MI 
division. As a consequence of crossover and chiasmata formation during meiotic 
recombination, parental homologs acquire a unique bivalent chromosome con-
figuration. Maintenance of the bivalent structure is regulated by the cohesin 
protein complex that binds homologs together at the crossovers and sister 
chromatids at the centromere [reviewed in (Webster and Schuh, 2016)]. At this 
stage, the oocyte remains quiet at the state of dictyate arrest, maintained by high 
levels of cAMP (Conti et al., 2002; DiLuigi et al., 2008), and will not resume 
meiosis until puberty. Following LH surge in adulthood, oocyte cAMP levels 
decline and MI progresses: meiotic spindle gets assembled and bivalents align 
on the metaphase I plate. Monopolar attachment of homologs to spindle 
microtubules (MTs) is mediated by kinetochores (k-MT attachment) that are 
assembled on the centromeres of homologous chromosomes to generate tension 
by counteracting the pulling force of spindle MTs. Meiotic spindle then 
migrates to the oocyte cortex by actin-dependent mechanism to facilitate the 
first polar body formation (Schuh and Ellenberg, 2008). During MI division, 
only cohesin holding the two homologs is removed by protease separase, while 
the sister-chromatid cohesion in the centromeric region is maintained by REC8 
protein that also orients kinetochores, so that sister chromatids move to the 
same pole (Watanabe and Nurse, 1999). REC8 itself is protected from cleavage 
by Shugoshin proteins (Sho), preventing premature segregation of sister 
chromatids at anaphase I (Kitajima et al., 2004; Lee et al., 2008; Llano et al., 
2008). As a result of the first asymmetrical division, the oocyte segregates half 
of the homologous chromosomes into the diploid polar body I that gets extruded 
from the oocyte upon cytokinesis (Fig. 2). In subsequent meiosis II, the second 
meiotic spindle is formed and already sister chromatids align on the MII 
spindle. At this stage the oocyte is ovulated and remains arrested at metaphase 
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II, awaiting fertilization. MII arrest is mediated by cytoplasmic activity, known 
as cytostatic factor (CSF), that blocks cell cycle progression by inhibiting a core 
component of the cell cycle regulatory machinery – anaphase-promoting 
complex/ cyclosome (APC/C) (Schmidt et al., 2006). The CSF activity and 
inhibition of APC/C is regulated by early mitotic inhibitor 2 (EMI2) as a part of 
the Mos-MAPK pathway, which is required for maintaining CSF-mediated 
arrest (Tung et al., 2005; Inoue et al., 2007). Once fertilized, the oocyte 
overrides metaphase arrest, centromeric cohesin is eliminated and bipolar k-MT 
attachment segregate sister chromatids towards opposite spindle poles, resulting 
in MII oocyte and a haploid polar body II.  
 
 
 
Figure 2. Schematic representation of oocyte nuclear maturation during meiosis. 
Following DNA replication, homologous chromosomes undergo pairing, synapsis and 
recombination, after which primary oocytes remain in meiotic arrest. Hormonal surge in 
adulthood triggers ovulation and exit from prophase arrest: meiotic spindle assembles 
and migrates to the oocyte cortex. Upon completion of meiosis I, half of homologous 
chromosomes segregate into the first polar body and the oocyte now contains a diploid 
set of chromosomes. A second meiotic spindle assembles around the remaining diploid 
chromosomes of the oocyte and the ovulated egg arrests again at second meiotic 
metaphase until fertilized. Finally, fertilization of the ovulated egg triggers the onset of 
sister chromatid segregation into the second polar body and completion of the second 
meiotic division. The resulting zygote now contains two haploid pronuclei, one from the 
mother and from the father. Figure based on (Clift and Schuh, 2013). 
 
 
1.2. Fertilization 
The essence of fertilization in all higher animals is the fusion of male and 
female gametes that will give rise to a new organism. The fertilizable life span 
of the ovulated human oocyte is relatively short and is estimated to be 12–24 
hours after ovulation. At this point, the mature oocyte is surrounded by two 
substantial layers: (i) a glycoprotein matrix, or zona pellucida (ZP), that was 
synthesized and secreted by the oocyte during follicular development and (ii) a 
layer of expanded cumulus cells. During normal fertilization, only one sperm 
must penetrate these layers to fuse with oocyte plasma membrane. Prior to 
fertilization, the sperm undergoes several biochemical changes (known as sperm 
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capacitation) that increase sperm motility and prepare it for acrosome reaction, 
necessary to penetrate the egg’s tough membrane, release it from meiotic sleep 
and form a zygote (Evans and Florman, 2002). Hence, fertilization encompasses 
a sequence of coordinated molecular events that involve sperm-egg binding and 
fusion, oocyte activation and subsequent cellular reprogramming to transform 
highly specialized haploid germ cells into a totipotent diploid zygote [reviewed 
in (Clift and Schuh, 2013)].  
 
 
1.2.1. Sperm-egg binding and oocyte activation 
Oocyte fertilization initially begins with sperm cell binding to zona pellucida of 
the egg, which is made of a few glycoproteins, designated as zona pellucida 
binding protein 1 (ZP1) to ZP3 in mice and ZP1 to ZP4 in humans (Gupta et al., 
2012). Zona pellucida proteins are modified with specific oligosaccharides that 
enhance gamete binding affinity (Pang et al., 2011). Although the precise 
mammalian sperm-egg interaction mechanisms remain elusive, earlier studies 
suggest that ZP3 is the key sperm-binding receptor in mouse oocytes, but in 
humans also ZP1 and ZP4 participate in binding of capacitated spermatozoa 
(Gupta et al., 2012). Subsequent sperm-egg interaction is preceded by 
acrosomal exocytosis that releases a mixture of glycohydrolytic and proteolytic 
enzymes at the binding site to help the sperm to digest through zona pellucida 
and fuse with egg’s plasma membrane (Abou-Haila and Tulsiani, 2000). 
Spermatozoa that fail to undergo acrosome reaction will not be able to digest ZP 
of intact oocytes, making acrosome a crucial player in the fertilization process.  
Following fertilization and fusion of egg and sperm membranes, the oocyte 
establishes zona pellucida and plasma membrane block to preclude the 
attachment of additional sperms and prevent polyspermic fertilization (Gardner 
et al., 2007). In mammals, the polyspermy block is achieved through cortical 
reaction, triggered by Ca2+ oscillations in the egg upon fertilization (Fig. 3). The 
wave of Ca2+ is likely to be initiated by the sperm phospholipase Cζ (PLCζ), 
which promotes the release of free Ca2+ from endoplasmic reticulum by 
activating the Ca2+ channel, targeting inositol phosphate cascade (Miyazaki et 
al., 1992; Saunders et al., 2002; Hachem et al., 2017). As a result of Ca2+ indu-
ced egg activation, the oocyte releases Golgi-derived cortical granules from its 
cortex, which contain several enzymes that modify zona pellucida proteins to 
ensure monospermic fertilization and proper preimplantation embryo develop-
ment (Liu, 2011). One of the key components of cortical granules is an oocyte-
specific protease, ovastacin, that breaks down the sperm-docking domain of 
ZP2, altering the topology of zona pellucida and making it impenetrable to 
sperm (also referred to as zona hardening) (Burkart et al., 2012).  
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Figure 3. Fertilization-induced events in the oocyte. Following sperm-egg binding, 
sperm-derived phospholipase Cζ (PLCζ) is released into the oocyte cytoplasm, where it 
promotes the generation of ligand IP3 (inositol 1,4,5-trisphosphate) that targets  
Ca2+-channels, causing the release of Ca2+-ions from the endoplasmatic reticulum. As a 
result, Ca2+ oscillations (i) trigger cortical granule exocytosis to block polyspermy, (ii) 
activate CAMKII pathway, releasing APC/C from EMI2-mediated arrest to promote 
exit from meiotic metaphase II arrest, and (iii) induces the onset of maternal mRNA 
translation to promote the transition from meiosis to mitosis. Adapted by permission 
from (Clift and Schuh, 2013). 
 
In addition to polyspermy block, changes in cytosolic Ca2+ levels trigger exit 
from meiosis and translation of maternal mRNAs (Fig. 3), which is the last 
phase of oocyte activation (Ducibella et al., 2002). The rise of intracellular Ca2+ 
concentration within the oocyte activates Ca2+/calmodulin-dependent protein 
kinase II (CaMKII), which releases APC/C from EMI2-mediated CSF arrest 
(Rauh et al., 2005). This event involves sequential phosphorylation of EMI2 by 
CaMKII, and recruited polo-like kinase 1 (PLK1) that, together with SCF 
(SKP2–cullin 1–F-box protein) ubiquitin ligase complex, mark EMI2 for 
proteosomal degradation (Schmidt et al., 2005). With EMI2 out of the way, 
activated APC/C eliminates key cell-cycle regulators, such as cyclin B and 
securin, and promotes meiotic resumption, followed by the formation of a 
second polar body and a female pronucleus. At the same time, the sperm 
undergoes a series of morphological and biochemical transformations, including 
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chromatin remodeling, which lead to the development of a functional male 
pronucleus (McLay and Clarke, 2003). Finally, the formation of maternal and 
paternal pronuclei delineates the completion of fertilization and the oocyte is 
now denoted a zygote. The zygote then prepares to enter its first post-zygotic 
cell division. 
 
 
1.2.2. Transition from meiotic to mitotic cell cycle 
The transition from oocyte to embryo is one of the most complex and fasci-
nating phases of early mammalian development. The newly formed zygote must 
abandon the inherited germ cell-specific traits and erase its epigenetic memory 
to achieve totipotency. In addition, it needs to reprogram its cell-cycle machi-
nery from the reductional meiotic division to equational mitotic division, so the 
extensive re-organization of the zygote includes epigenetic reprogramming, 
switch from acentrosomal meiotic spindle to centrosomal mitotic spindle and 
from asymmetric to symmetric cell divisions [reviewed in (Clift and Schuh, 
2013)]. 
 
 
Epigenetic reprogramming 
Epigenetic reprogramming in zygotes is a highly dynamic process that is pivotal 
for correct embryonic development and accurate chromosome segregation during 
first post-zygotic cleavages. Initially, sperm DNA is highly coated with 
protamines that allow tight packaging of the paternal genome into the sperm 
head. Such difference in chromatin assembly creates an epigenetic asymmetry 
between paternal and maternal genomes in the zygote that needs to be resolved 
for successful mitotic progression, as epigenetic asymmetry makes paternal 
chromosomes more susceptible to kinetochore attachment and missegregation 
errors (Burton and Torres-Padilla, 2014; van de Werken et al., 2015). Most likely, 
the genome-wide epigenetic reprogramming of parental genomes is 
predominantly controlled by oocyte-specific factors. This view is supported by 
somatic cell nuclear transfer (SCNT) techniques, in which the anucleated 
oocyte, containing oocyte-specific factors in its remaining cytoplasm, is able to 
reprogram a fully differentiated somatic cell into a newly developing embryo. 
During maturation, growing oocytes acquire histone-assembly activity by ac-
cumulating and translating mRNAs that encode histone chaperons, required for 
nucleosome assembly (McLay and Clarke, 1997; McLay et al., 2002). Shortly 
after fertilization, the sperm undergoes decondensation, by which protamines 
are removed from paternal pronucleus and replaced by maternally-derived 
histones (e.g. by H3 variant H3.3), establishing de novo nucleosomes (Torres-
Padilla et al., 2006; Lin et al., 2014; Wen et al., 2014). As the embryo develops, 
chromatin becomes more accessible and new sites appear at promoters, as well 
as at exonic, intronic and intergenic regions (Lu et al., 2016). 
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When sperm chromatin protamines are replaced by oocyte cytoplasmic 
histones, the paternal genome undergoes active DNA demethylation to create a 
hypomethylated epigenome in the embryo (Fulka et al., 2004; Guo et al., 2014; 
Smith et al., 2014). The key modulator of this process is TET3 enzyme that 
oxidates 5-methylcytosine into 5-hydroxylmethylcytosine, which serves as an 
intermediate state between methylated and unmethylated DNA (Gu et al., 
2011). The maternal genome remains stable at this point, as it is protected from 
TET3-mediated oxidation by the DNA demethylation controlling protein 
DPPA3, which prevents binding of TET3 to chromatin (Nakamura et al., 2007; 
Bakhtari and Ross, 2014). Apart from TET3-mediated active DNA demethy-
lation, several other parallel pathways may also facilitate this process, like 
DNA-repair based mechanisms (Hajkova et al., 2010; Ladstatter and Tachibana-
Konwalski, 2016). Subsequently, both parental genomes undergo passive repli-
cation-dependent DNA demethylation during embryo cleavage-stage develop-
ment (Guo et al., 2014). However, during epigenetic reprogramming, both 
maternal and paternal pronuclei are not entirely demethylated and retain im-
printed loci, established during male and female gametogenesis (Li and Sasaki, 
2011). The maintenance of imprinted genes ensures the parent-of-origin specific 
gene expression, necessary for normal pre- and postnatal development.  
 
 
Transition from meiotic to mitotic spindle 
One of the first steps in erasing the meiotic footprint is re-organization of the 
chromosome cohesin complex. The meiosis-specific cohesin complex that 
contains REC8, which is essential for reductional division, is rapidly replaced 
by the mitotic cohesin complex, containing SCC1 (Tachibana-Konwalski et al., 
2010). Although SCC1 has no role in meiosis, its accumulation in the oocyte is 
likely a prerequisite for the rapid switch from meiotic to mitotic cohesin 
complex immediately after fertilization. The equitable mitotic division also 
depends on the formation of a centrosomal bi-polar spindle. During mitosis the 
cell’s two centrosomes, which consist of a pair of centrioles surrounded by an 
amorphous pericentriolar matrix, move towards the opposite poles and facilitate 
capture and alignment of chromosomes before equally segregating them 
between the two daughter cells. However, oocytes do not contain canonical 
centriole-containing centrosomes, as centrioles are eliminated during oogenesis 
by unknown mechanisms, and so conventional centrosomes are unable to form. 
In most mammals, including human, the incoming sperm contributes a 
centriole to the egg at fertilization. Paternally-derived centrioles can already be 
visualized in the human zygote, suggesting that the switch from acentrosomal 
meiotic spindle to centrosomal mitotic spindle in humans embryos occurs 
immediately after fertilization (Sathananthan et al., 1996; Sathananthan, 1998). 
In contrast, mouse and other rodents are the only mammals, where sperm 
centriole gets degenerated during spermatogenesis and first post-zygotic divi-
sions also occur in the absence of centrioles, following the meiosis-like pattern 
23 
of spindle assembly. The de novo centriole production in mice establishes 
gradually and the spindle adopts typical mitotic features upon embryo develop-
mental progression (Courtois et al., 2012). However, a question remains, 
whether the sperm centriole-mediated spindle assembly is the only exclusive 
mechanism in human zygotes, taking into account the ability of human oocytes 
to spontaneously cleave without being fertilized, a phenomenon known as 
parthenogenesis (Winston et al., 1991; Paffoni et al., 2007; de Fried et al., 
2008). 
 
 
Transition from asymmetric meiotic to symmetric mitotic division 
Mammalian oocyte maturation is accompanied by asymmetric cell division that 
produces a large egg and a small polar body. In contrast, the first post-zygotic 
division needs to be symmetric to produce two cells of the same size that 
equally inherit both genetic material and maternal cytoplasmic material. In 
order to achieve that, two parental pronuclei need to be centrally positioned. 
Prior to the formation of the first mitotic spindle in zygotes, microtubule-
dependent movement of maternal and paternal pronuclei towards each other 
takes place, referred to as karyogamy. In mice and rodents, pronuclei centering 
depends on dynamic actin networks that maintain central spindle positioning 
and ensure symmetrical first mitotic division (Chew et al., 2012; Chaigne et al., 
2016). In other mammalian species, the paternally inherited centrosome 
nucleates microtubules to form the sperm aster, which most likely allows the 
female pronucleus to associate with microtubules upon their expansion and 
move towards the male pronucleus in a motor dynein-dependent manner 
(Reinsch and Gonczy, 1998; Payne et al., 2003). Subsequently, the sperm 
centrosome generates the mitotic spindle that segregates chromosomes to two 
equal embryonic cells, called blastomeres. 
 
 
1.3. Stages of preimplantation embryo development 
Preimplantation embryo developmental processes are highly conserved among 
mammals, as they all progress through the same morphological stages, i.e. from 
zygote to blastocyst (Fig. 4). In humans, the first cytokinesis is estimated to 
occur after 14–15 hours post fertilization (Chavez et al., 2012; Vera-Rodriguez 
et al., 2015) and the first division itself occurs ~26–28 hours post fertilization 
(Gardner and Balaban, 2016). Subsequently, the developing embryo undergoes 
a series of rapid cellular proliferations that increase the number of blastomeres 
without changing the overall size of the embryo. Progression through 2-cell,  
4-cell and 8-cell is termed cleavage-stage of development, which is charac-
terized by rather synchronous cell divisions, leading to morphologically identi-
cal blastomeres. At the end of cleavage-stage, blastomeres develop gap junc-
tions and initiate embryo compaction to form a morula on day 4 of develop-
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ment, which contains 16–32 cells and marks first morphogenetic and cellular 
differentiation. During the process of compaction, blastomeres increase inter-
cellular adhesion and undergo cell polarization, creating outer polarized cells 
and inner apolar cells (Zernicka-Goetz et al., 2009). Consequently, polarity and 
cell division orientation lead to lineage specification into inner cell mass (ICM) 
and trophectoderm (TE) cells. Shortly after the development of morula, ion 
pumps become assembled on the membranes of TE cells that actively transport 
sodium, creating the osmotic gradient and promoting the formation of a fluid-
filled cavity, known as blastocoele (Houghton et al., 2003). Generation of the 
blastocoele cavity also defines the beginning of the blastocyst formation. The 
progressive accumulation of blastocoele fluid (BF) coupled with continuous cell 
proliferation leads to the expansion of the blastocyst and thinning of zona 
pellucida that has been surrounding the embryo during first days of develop-
ment. At this point, different cell lineages can be clearly distinguished from 
each other: the outer layer of TE cells will contribute to uterine wall invasion 
and formation of the placenta, while ICM will give rise to the future fetus. 
Eventually, zona pellucida develops a crack and the embryo escapes from its 
enclosure, leaving behind an empty zona pellucida shell. The zona-free hatched 
blastocyst is now ready to implant and continue its post-implantation 
development. 
 
 
1.3.1. Embryonic genome activation 
Early embryo development begins in transcriptional silence and the genetic 
control of first cell divisions initially rely on maternally-derived RNAs and 
proteins, the majority of which will be degraded during the maternal-to-zygotic 
transition. The duration of embryonic quiescence differs between mammalian 
species, but all embryos gradually develop the ability to transcribe genes from 
their newly formed genomes. The requirement for embryonic genome activation 
(EGA) is absolutely essential for embryogenesis, as it takes the embryo from a 
state of almost no transcription to a state of self-sustained cellular control, 
where up to thousands of genes are transcribed to ensure normal embryo 
development and survival. Mouse embryos exhibit the earliest transition from 
maternal to embryonic transcription already at 2-cell stage (Hamatani et al., 
2004). The shift to EGA in humans occurs on day 3 after fertilization 
approximately at 4–8-cell stage (Fig. 4) (Braude et al., 1988; Dobson et al., 
2004), which is similar to non-human primates (Wang et al., 2017). Changes in 
nuclear and chromatin structure and cytoplasmic content appear to regulate 
periods of transcriptional activation [reviewed in (Lee et al., 2014)].  
The transition to EGA has been extensively studied in model organisms, 
especially in the mouse, but detailed information for human embryos has also 
recently emerged. In mammalian embryos, including humans, initiation of EGA 
consists of two waves, which are characterized by a dramatic transcriptional 
turnover (Xue et al., 2013; Graf et al., 2014). In the first wave, which in humans 
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occurs during the progression to the 4-cell stage, the maternally inherited 
transcripts are either significantly downregulated or degraded (Fig. 4). 
 
Figure 4. Preimplantation development of human embryos. Key morphological 
features are represented for each embryonic stage, accompanied by the corresponding 
time-lapse image. During cleavage-stage development the transition to embryonic 
genome activation (EGA) occurs: maternally inherited transcripts are gradually 
degraded in the first wave of EGA that lasts up 4-cell stage and in the second wave, 
which occurs after 8-cell stage, embryo genome becomes accessible to transcription 
factors that activate embryonic gene expression. Time-lapse images adapted by 
permission from (Gardner and Balaban, 2016).  
 
In the second wave, which in humans occurs after 8-cell stage, there is a signi-
ficant upregulation of genes, involved in RNA metabolism and processing, 
indicating that embryonic transcriptional machinery is being established. By the 
blastocyst stage of development, already genes that guide cell linage commit-
ment become activated (Zhang et al., 2009; Vassena et al., 2011; Yan et al., 
2013). Importantly, timely discard of maternal mRNAs is a necessity for success-
ful embryonic reprogramming, as failure to do so can result in developmental 
defects and early embryonic arrest (DeRenzo and Seydoux, 2004; Dobson et al., 
2004; Wong et al., 2010). The main purpose of eliminating maternal material is 
to discard proteins, necessary for oocyte maturation and homeostasis, and erase 
the germline program to pave the way for somatic development. Although the 
precise molecular mechanisms of maternal decay in mammals are still being 
elucidated, two forms of maternal clearance have been described in Drosophila 
and Xenopus models: the maternal mode, which relies on maternal factors, and 
the zygotic mode that takes advantage of the de novo zygotic transcription 
Maternal transcripts 
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[reviewed in (Yartseva and Giraldez, 2015)]. The maternal mode of mRNA 
decay is thought to be initiated upon oocytes activation and involves RNA-
binding proteins that destabilize maternal transcripts through mRNA 
deadenylation. This process is most likely regulated by the small non-coding 
PIWI-interacting RNA (piRNA) pathway that triggers maternal mRNA 
degradation (Rouget et al., 2010). In the zygotic mode of clearance, de novo 
expression of another small non-coding RNAs, microRNAs (miRNAs), is a 
common strategy to induce maternal mRNA translation repression, 
deadenylation and decay. Together these two activities shape the embryonic 
gene expression landscape to give rise to a reprogrammed embryo.   
 
 
 
2. Technology of reproduction:  
from assisted reproduction to single-cell analysis 
2.1. Assisted reproductive technology 
Reproductive medicine is one of the fastest developing fields that has made 
tremendous progress in fertility treatment in a relatively short time: from the 
development of in vitro fertilization (IVF) in the late 1970s and intracyto-
plasmic sperm injection (ICSI) in 1990s to the successful implementation of the 
ovarian and uterine transplant that both resulted in birth of healthy babies in 
2014 (Brannstrom et al., 2015; Demeestere et al., 2015). One of the best 
examples in reproductive medicine, where fundamental and translational 
science performed in research laboratories goes hand-in-hand with clinical 
practice, is assisted reproductive technology (ART) that utilizes different 
techniques of oocyte, sperm and embryo manipulations to improve fertility 
treatments. Over the past decades, there has been a profound impact of ART on 
biomedical research and the use of assisted reproduction continues to increase 
globally (Dyer et al., 2016). Since the birth of the first IVF baby (Steptoe and 
Edwards, 1978), over 6 million children have been conceived via ART and 
fertility treatments have become standard care in many countries (Maheshwari 
et al., 2016). This undoubtedly leads to the increasing need to transfer 
knowledge from bench to bedside, but despite the progress made in clinical and 
laboratory ART protocols, including embryo selection for transfer, the preg-
nancy rate per embryo transfer after single treatment cycle still lingers at around 
30% worldwide (Dyer et al., 2016). This highlights the importance of 
understanding in vivo regulation of oocyte maturation and subsequent 
preimplantation development in order to refine assisted reproduction, so that in 
vitro techniques can mimic natural conditions as closely as possible. 
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2.1.1. In vitro fertilization  
In vitro fertilization and embryo transfer is the most commonly performed 
procedure in ART. Initially, IVF was indicated for tubal factor infertility, 
endometriosis, male factor infertility and idiopathic or unexplained infertility. 
Nowadays, given the social and financial pressure encountered in many 
countries, especially in the Western world, women continue to postpone the age 
of first pregnancy for various socioeconomic and educational reasons. As a 
consequence, more and more couples turn to IVF to overcome age-related sub-
fertility. Whether for medical or non-medical reasons, standard IVF procedure 
involves controlled ovarian stimulation (COS), oocyte retrieval, in vitro oocyte 
fertilization and in vitro embryo culture, followed by embryo transfer back to 
the uterus. The improved molecular understanding of folliculogenesis and 
oocyte maturation has enabled to implement COS as a part of routine IVF 
process that allows to retrieve numerous oocytes for fertilization per cycle and 
to enhance the cumulative pregnancy rate. The procedure comprises three basic 
elements: (i) stimulation of multi-follicular development by exogenous gonado-
tropins, (ii) suppression of premature ovulation by co-treatment with gonado-
tropin-releasing hormone agonist or antagonist and (iii) triggering final oocyte 
maturation by human chorionic gonadotropin administration 36–38 hours prior 
to oocyte retrieval (Pacchiarotti et al., 2016). In humans, COS is considered to 
be a safe procedure, since embryo quality, implantation rates and pregnancy 
outcomes are comparable between stimulated and natural IVF cycles (Ziebe et 
al., 2004; Sunkara et al., 2016). Following COS, oocytes are retrieved via 
transvaginal puncture and subsequent IVF procedure may involve conventional 
in vitro fertilization, in which prepared sperm is added to the dish with cultured 
oocytes, or in case of severe male infertility by performing ICSI, in which 
fertilization is achieved by injecting single sperm into the oocyte (Palermo et 
al., 1992). When performing ICSI, the cumulus cell layer is removed from the 
oocyte and sperm is injected only into the mature oocytes, while in case of 
conventional IVF, cumulus cells remain intact. For this reason ICSI can also be 
the preferred method for fertilization, if embryo testing is indicated, as it would 
minimize the risk of contamination. Fertilization is then assessed 16–20 hours 
post insemination (p.i.) by inspecting the pronuclei status and polar body 
formation. About 70% of oocytes will be fertilized and further embryo 
development will be evaluated under the stereomicroscope or monitored using 
time-lapse imaging (TLI) system that takes digital images of an embryo at set 
time intervals (Armstrong et al., 2014). Finally, only good quality embryos are 
transferred back to the uterus on either day 3 or day 5, depending on a doctor-
patient agreement. With the development of embryo cryopreservation techniques, 
frozen embryo transfer (FET) became available, which can potentially improve 
IVF outcome compared to fresh embryo transfer due to a better embryo-
endometrium synchrony (Roque et al., 2013). Major advances in vitrification 
protocols also led to an incredible story of a woman, who gave birth to a baby that 
developed from an embryo cryopreserved 24 years ago, holding the all-time 
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record for the longest-frozen embryo to come to birth 
(http://www.bbc.com/news/world-us-canada-42420864). In parallel, there have 
also been substantial improvements in human embryo culture conditions, 
including the development of a two-step protocol, based on embryos metabolic 
needs at different stages: the first medium, high in lactate and pyruvate, is used 
for the first three days of culture, while rich in glucose second medium is used 
from day 3 to day 5 (Gardner et al., 1998). However, in recent years the 
growing awareness about the impact of different culture conditions on 
embryonic development sparked a strong demand for full transparency, 
concerning commercially available culture medium composition (Morbeck et 
al., 2014; Chronopoulou and Harper, 2015; Salvaing et al., 2016; Sunde et al., 
2016; Morbeck et al., 2017).  
 
 
2.1.2. Oocyte in vitro maturation  
Oocyte in vitro maturation (IVM) refers to the maturation of immature oocytes 
in culture after their recovery from antral follicles. In vitro embryo production 
coupled with IVM has been the main strategy for producing offsprings in 
agricultural breeding programs. The ability to obtain oocytes, destined for 
atresia, has major benefits for domestic farm animal production, and the vast 
application of IVM technology likely results in over 100,000 births per year in 
cattle (The International Embryo Transfer Society Report for 2016). This is in 
complete contrast to the estimated >5,000 human births worldwide (Sauerbrun-
Cutler et al., 2015). The main advantage of using IVM in humans is the ability 
to eliminate the risk of developing ovarian hyperstimulation syndrome (OHSS) 
and to reduce the overall costs associated with hormonal stimulation. Although 
achieving pregnancy and live birth via IVM in humans is less successful than by 
using conventional IVF/ICSI (Buckett et al., 2008; Gremeau et al., 2012), it 
might be a safer and more beneficial option for women with polycystic ovarian 
syndrome (PCOS) or cancer patients, for whom hormonal stimulation is 
contraindicated. In PCOS patients, standard COS can lead to potentially lethal 
OHSS, so the alternative option for these patients is to collect immature follicles 
during natural or mildly stimulated cycle (Shalom-Paz et al., 2012; Siristatidis 
et al., 2015). In the field of oncofertility, IVM and oocyte cryopreservation can 
be a treatment option for patients with estrogen receptor positive cancer history, 
as COS elevates serum estradiol levels, and for young women in general, who 
are undergoing gonadotoxic cancer therapy that can lead to loss of ovarian 
function and infertility (De Vos et al., 2014). Despite the attractive features of 
fertility preservation, providing culture system that is similar to follicular 
environment will be the most important challenge for the development of IVM 
protocols.  
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2.2. Single-cell technology 
Our understanding about the structure and regulation of the genome is largely 
based on millions of cells analysed in bulk, but such approach would neglect 
any heterogeneity present in a subset of cells within the cellular population. For 
this reason, the past decade can be regarded as one of the most exciting in science 
due to the advent of powerful single-cell technologies that enable studying life 
down to the very core unit – one cell. The field of single-cell research represents 
a turning point in cell biology that, with its rapid advance, can provide novel 
insight into complex biological networks, ranging from the diversity of micro-
biome to pathogenesis of human disease (Saadatpour et al., 2015; Proserpio and 
Lonnberg, 2016; Tolonen and Xavier, 2017). Pioneering single-cell assays are 
now available for genome, epigenome, transcriptome, metabolome and pro-
teome, and integrating all these disciplines into a single multi-omics assay will 
undoubtedly revolutionize biomedical research (Bock et al., 2016; Macaulay et 
al., 2017). Here, only a minor fraction of single-cell technology possibilities 
will be discussed, focusing on single-cell genomics that scrutinizes genomic 
architecture of individual cells and characterizes the incidence and consequence 
of genomic instability in physiology and disease (Wang et al., 2012; McConnell 
et al., 2013; Demeulemeester et al., 2016). In embryo research, single-cell 
genomics aims to unravel the onset and mechanistic origins of embryonic 
aneuploidy and evaluate the role of chromosomal mosaicism (the presence of 
cells with different genomic constitution) on embryo viability.  
 
 
2.2.1. Single-cell isolation 
The first step in any single-cell workflow is isolation of individual cells. A 
variety of well-established techniques can be used for efficient isolation of cells 
from a population, ranging from either manual or automated single-cell 
isolation, such as fluoresce-activated cell sorting (FACS) and microfluidic, to 
more complex procedures of laser capture microdissection (LCM) and single 
nucleus isolation (Table 1). Manual micromanipulation is a low-throughput 
method performed under the stereomicroscope, when only a small number of 
cells need to be analyzed. By using a simple mouth-pipette system or micro-
pipettes that utilize special capillaries for cell disassociation, it is possible to 
visually confirm successful cell isolation and collection. Micropipetting is used, 
when working with embryos, although it carries a risk of operator-bias. For 
other cellular samples, a more robust cell isolation can be achieved by high-
throughput and user-friendly FACS-based sorting, which uses either cell-type 
specific biomarkers or DNA dyes. Before separation, a cell suspension is made 
and the cells are labelled with fluorescent probes. FACS-based sorting has been 
successfully implemented in cancer research (Navin et al., 2011; Baslan et al., 
2012), however the major disadvantage of this method is that it requires a large 
starting number of cells in suspension, so FACS fails to isolate single cells from 
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a low quantity cell population. Secondly, the rapid flow in the machine can 
damage the cells or isolate more than one cell per well, leading to biased 
biological data. In recent years, various microfluidic devises have been intro-
duced that allow both isolation and subsequent amplification of single cells, an 
approach that has been widely adopted for different single-cell studies (Rowat 
et al., 2009; Wang et al., 2012; Xin et al., 2016). Microfluidic systems are a 
clear example of lab-on-a-chip devices that allow the compartmentalization and 
controlled management of nanoliter reactions using fabricated microfluidic 
chips. For instance, the automated Fluidigm C1™ system (Fluidigm Corporation, 
USA) captures cells from a cell suspension and provides visual confirmation 
that a single cell entered the reaction chamber for DNA or RNA amplification. 
Similarly to FACS, the main risk associated with the method is that multiple 
cells can enter the reaction chamber or some samples can be lost during sorting. 
Recently developed DEPArray™ technology (Silicon Biosystems, Italy) com-
bines both microfluidics and microelectronics together to collect single cells. 
Following immunofluorescent staining, cells are entrapped in so-called 
“dielectrophoretic” cages on the microfluidic cartridge that can be repositioned, 
allowing movement and isolation of individual target cells. Hence, the 
DEPArray™ automated platform enables to identify and recover viable specific 
or rare individual cells from a heterogeneous sample (Carpenter et al., 2014; 
Polzer et al., 2014).  
 
Table 1. Methods for single-cell isolation 
I. Single-cell suspension and manipulation 
Manual micropipetting Single-cell fluorescence 
activated cell sorting 
(FACS) 
Microfluidics 
+  visual confirmation 
+  only a few cells need to 
be collected 
–  operator bias 
–  low throughput 
 
+  high throughput 
+  sorting based on cell 
phenotype and cellular 
biomarkers 
–  large cell suspension 
required 
–  “leaking” of more than 
one cell 
–  putative damage to cell  
+  highly standardized and 
automated nanoliter 
reactions  
+  high throughput isolation 
with visual confirmation 
–  putative loss of cells 
II. Lasure capture microdissection III. Single nucleus suspension and 
sorting
+  retain topological information of the 
cell 
+  isolation of cells from fixed solid or 
frozen tissues 
–  potential damage to cell 
–  contamination by neighbouring cells 
+  isolation of single nuclei from fresh or 
frozen tissue 
+  eliminates the need to isolate intact cells 
+  can be used for both DNA and RNA 
studies 
–  potential loss of micronuclei and/or 
genetic material 
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Many of the above mentioned approaches require cells or nuclei in suspension; 
so alternatively, LCM method can be used to cut cells from fixed, frozen or 
solid tissues that require harsh mechanical and enzymatic digestion. LCM 
retains the spatial information of isolated cells in the context of tissue 
topography (Nichterwitz et al., 2016), but there is a high risk of contamination 
from neighboring cells. Additionally, the laser can damage target cells, so this 
methodology is not widely used for single-cell analysis due to various technical 
difficulties.  
 
2.2.2. Single-cell amplification 
One diploid human cell contains only about 6–7 pg of DNA, while genomics 
platforms require up to several hundred nanograms of input material. Hence, 
once the cell is isolated, it needs to undergo rounds of whole-genome ampli-
fication (WGA) prior to application of high-throughput technologies. There are 
several commercially available WGA kits, which are either polymerase chain 
reaction (PCR)-based or use isothermal multiple displacement amplification 
(MDA) (Fig. 5), and the choice of WGA strongly depends on the study question, 
as some methods are more suitable than others to detect specific genetic varia-
tions (Macaulay and Voet, 2014). PCR-based methods include primer extension 
pre-amplification PCR (PEP-PCR) (Zhang et al., 1992), ligation-mediated PCR 
(LA-PCR) (Klein et al., 1999) and degenerate oligonucleotide-primed PCR 
(DOP-PCR) (Cheung and Nelson, 1996) (Fig. 5B). Because PCR-based WGA 
suffers from low genome coverage and lack of proofreading of used thermo-
stable polymerases that introduce artifacts during amplification steps, these 
methods are mostly preferred for copy-number profiling of single cells (Treff et 
al., 2011; de Bourcy et al., 2014; Ning et al., 2015). In contrast, MDA is based 
on an isothermal reaction, which utilizes high-fidelity phi29 polymerase with 
high processivity and strand displacement activity (Fig. 5A). However, like 
PCR-based amplification, MDA is an exponential amplification that causes 
non-reproducible overamplification in certain genomic regions and underampli-
fication in other regions. For this reason, copy-number variation (CNV) calling 
is distorted by noisy profiles and ineffective normalization that skew data 
interpretation. Instead, MDA is the most suitable method for single nucleotide 
polymorphism (SNP)-genotyping, as it produces high molecular weight pro-
ducts and offers greater genome coverage with lower error rates than the initial 
PCR-based methods (Treff et al., 2011).  
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Figure 5. Whole-genome amplification methods. (a) In multiple displacement 
amplification (MDA), an isothermal reactions starts by annealing random hexamer 
primers to the template and DNA synthesis is carried out by high-fidelity phi29 DNA 
polymerase with strand displacement activity. (b) PCR-based WGA technologies: (i) In 
primer-extension pre-amplification (PEP)-PCR DNA is amplified with oligonucleotides 
of complete degenerate sequence using permissive thermocycling with increasing 
annealing temperatures. (ii) Degenerate-oligonucleotide primer (DOP)-PCR applies 
hybrid oligonucleotides containing degenerate and defined sequence and is carried out 
in two steps: first thermocycling at low annealing temperatures for semi-random 
priming, followed by PCR at high annealing temperatures for non-random priming. (iii) 
In linker adaptor (LA)-PCR, DNA is sheared into small fragments and adaptors with 
universal sequence are ligated to DNA-ends, creating universal sequences for PCR 
amplification. (c) Combined displacement amplification with PCR (DA-PCR) under-
goes multiple rounds of displacement pre-amplification to generate unique DNA 
sequences for PCR amplification. (d) MALBAC uses specific oligonucleotide design 
that allow full amplicons to form looped pre-amplification products that are protected 
from further pre-amplification until PCR amplification, resulting in a more uniform 
representation of the genome. Adapted by permission from (Van Loo and Voet, 2014) 
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In an attempt to overcome the low coverage of PCR-based approaches and lack 
of uniformity of isothermal MDA, recent WGA methods have combined 
features of both MDA- and PCR-based amplifications, in which case multiple 
rounds of displacement pre-amplification of the single-cell genome is followed 
by subsequent PCR amplification of generated DNA fragments. A modified 
version of this approach involves multiple annealing and looping-based ampli-
fication (MALBAC), which forms circular DNA fragments that will no longer 
be available as a template until subsequent PCR amplification of generated 
amplicons (Fig. 5D) (Zong et al., 2012). Due to generation of loops during the 
first round of amplification, MALBAC results in a more uniform representation 
of the genome. Similarly to PCR-based WGA, both methods use low-fidelity 
polymerases compared to MDA, making them more suitable for copy-number 
profiling. However, the demand for unbiased single-cell genome representation 
still inspires researches to develop novel WGA protocols (Picher et al., 2016; 
Chen et al., 2017) or even omit this costly artifacts-introducing step from the 
single-cell workflow (Xi et al., 2017; Zahn et al., 2017).  
 
 
2.2.3. Single-cell DNA microarrays 
Single-cell array comparative genomic hybridization 
The array comparative genomic hybridization (aCGH) technology uses specially 
designed slides, usually made out of glass, carrying unique DNA segments in 
certain positions, known as probes. The size and the genomic distance between 
these probes (probe spacing) determine the resolution of aCGH. As the name 
implies, for aCGH analysis, the extracted test DNA sample and reference DNA 
with known karyotype are first labelled with different fluorescent dyes. Next, 
both denatured genomic DNAs are co-hybridized onto the DNA-microarray 
containing single-stranded probes. By measuring the fluorescence intensity ratio 
of the test and reference samples, DNA copy-number alterations can be detected 
across the genome to a resolution as low as 1–2 Kb on high-density arrays 
(Conrad et al., 2010). However, aCGH experiments require substantial amount 
of input DNA material for reliable signal detection and copy-number analysis, 
so it has mainly been performed using bulk DNA samples. The first successful 
attempts to detect full and segmental chromosome losses and gains from whole-
genome amplified single cells used arrays that contained large genomic clones, 
known as bacterial artificial clones or BACs (Le Caignec et al., 2006; Fiegler et 
al., 2007). Compared to fluorescence in situ hybridization (FISH) that can 
evaluate a few loci at time, the ability to screen all 24 chromosomes was a 
defining moment for single-cell genomics, but it became clear that WGA-
induced background noise reduces the sensitivity and specificity of conven-
tional copy-number calling algorithms. Allele drop-out (ADO) and preferential 
amplification, as well as chimeric DNA molecules generated during WGA, can 
bias the fluorescent signal, leading to false positive findings. Importantly, cell-
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cycle stage can also interfere with accurate copy-number profiling, as cells in S-
phase undergo DNA replication that can be misinterpreted as genomic 
imbalance (Dimitriadou et al., 2014). To overcome these issues, several custom 
data analysis pipelines have been developed over the few years, including the 
commercialized 24Sure Microarrays platform (Illumina Inc., currently dis-
continued), that sought to reduce WGA-bias and enable reliable copy-number 
detection (Cheng et al., 2011; Konings et al., 2012; Czyz et al., 2014).  
 
 
Single-cell SNP-genotyping 
Despite the improvements, the main disadvantage of aCGH technology is that it 
can only detect numerical chromosomal abnormalities, but provides no infor-
mation on the presence of chromosomal mosaicism or copy-number neutral 
losses of heterozygosity, such as uniparental disomy (UPD), nor determines the 
parental origin of de novo genomic rearrangements. To compensate these draw-
backs, several groups made one step further and successfully hybridized single-
cell WGA products on high-density SNP-arrays that were initially developed to 
conduct genotyping procedures (Iwamoto et al., 2007; Vanneste et al., 2009; 
Johnson et al., 2010; Treff et al., 2010). SNP-array technology allows to 
genotype hundreds of thousands up to millions of SNPs, which are polymorphic 
in the human population, by hybridizing the DNA sample to array probes, using 
the same principle of complementary base pairing, utilized in aCGH. In a 
normal scenario, a variant is either homozygous (AA or BB) or heterozygous 
(AB), where A and B represent the two alleles with distinct nucleotide residues. 
As mentioned, the number of SNPs called, as well as genotyping and copy-
number calling accuracy can be significantly affected by different WGA 
methods (Treff et al., 2011), but the ability to exploit single-cell genotype calls 
together with their copy-number status enables to differentiate a genuine genomic 
aberration from WGA artifacts. By using SNP-arrays combined with sophisti-
cated bioinformatical approaches, unbalanced translocation, UPDs, complex 
structural rearrangements and parental origin of chromosomal aberrations were 
accurately identified in single embryo blastomeres (Vanneste et al., 2009; Treff 
et al., 2011; Voet et al., 2011; van Uum et al., 2012).  
 
 
2.2.4. Single-cell haplotyping  
The obtained SNP-genotypes can be used to reconstruct haplotypes, which 
represent a combination of genetic variants along a single chromosome, and 
determine the inheritance patterns of particular sets of DNA variants (Browning 
and Browning, 2011). Once again, the accurate detection of genetic variants and 
long-range haplotypes from SNP-array data remains challenging due to erro-
neous WGA. To date two genome-wide single-cell haplotyping methods have 
been developed that use SNP-array data: Karyomapping (Handyside et al., 
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2010) and single-cell haplotyping and imputation of linked disease variants 
(siCHILD) (Zamani Esteki et al., 2015). Due to a number of attractive features 
that address the issues of FISH and PCR-assays, both Karyomapping (provided 
by Illumina) and siCHILD (licensed to Agilent Technologies and marketed 
under OnePGT Solution) have been clinically implemented for embryo 
diagnostics (Natesan et al., 2014; Dimitriadou et al., 2017). First, both methods 
are generic and use available SNP genotypes from the parents and a close 
relative to reconstruct haplotypes of an embryo, including the locus of interest. 
Because the analysis is performed on a genome-wide scale, simultaneous 
screening for multiple Mendelian disorders and traits is possible. Both methods 
also minimize the issues associated with ADO, because there is no direct 
mutation analysis. Instead, the inheritance of DNA mutations is deducted from 
reconstructed haplotype blocks and even if some polymorphic markers will 
result in ADO, the significant part of variants, flanking the region of interest, 
will still remain. Finally, both methods can pinpoint to meiotic homologous 
recombination sites, which can break down the linkage of a pathogenic variant 
with its nearby SNPs, and also determine genome-wide copy-number profile of 
a single cell. However, Karyomapping only uses discrete SNP calls, therefore it 
struggles with reliable detection of post-zygotic chromosome gains compared to 
siCHILD, which, in addition to SNP genotypes, also relies on continuous BAF-
values and can also distinguish the meiotic segregation errors from mitotic ones, 
based on the recombination patterns. The shortcoming of both genome-wide 
haplotyping approaches that can limit the use of these techniques is the need for 
additional DNA from family members and inability to detect de novo mutations, 
for which no carrier family member exists [reviewed by (Vermeesch et al., 
2016)]. The modified version of siCHILD methodology (siCHILD-bovine) was 
at the core of the current thesis research (explained in detail in Chapter 3.2.3).  
 
 
2.2.5. Single-cell sequencing 
Massive parallel sequencing, also known as next-generation sequencing (NGS), 
is a high-throughput technology that allows billions of sequencing reactions in 
parallel in a time- and cost-effective manner. NGS has a number of advantages 
over SNP microarrays that can improve the resolution and accuracy of variant 
calling. Importantly, unlike SNP-arrays that use a limited amount of known 
SNP probes, NGS can examine virtually every nucleotide from the amplified 
cell, allowing the discovery of a full spectrum of de novo DNA mutations (Voet 
et al., 2013). The continuous reduction of sequencing costs has rendered NGS 
as a promising methodology for single-cell genomics studies, as the principles 
applied for SNP-array data analysis can be translated to sequences of single cell. 
For single-cell sequencing, WGA product is first shattered into smaller DNA 
fragments, from which a library of DNA templates for sequencing is generated. 
The resulting short sequence reads are mapped to the human reference genome 
and further investigated for genetic variation using computational workflows. 
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The first single-cell sequencing was performed to study copy-number aber-
rations in isolated tumor cells using DOP-PCR, which achieved ~10% physical 
coverage of single-genome (Navin et al., 2011; Baslan et al., 2012). Since then, 
substantial progress have been made over the recent years to improve genomic 
coverage, although the interpretation of single-cell sequencing data still remains 
complicated due to WGA errors that may be falsely interpreted as copy-number 
or nucleotide changes in the single-cell genome (Gawad et al., 2016). Single-
cell sequencing has been pivotal in cancer research, but it also gradually became 
a reality in the field of genetic profiling of embryos. By using long-fragment 
read sequencing technology, genetic variants can also be assembled into a single 
haplotype, thus enabling to reconstruct individual genome-wide haplotypes 
using direct phasing (Peters et al., 2012; Peters et al., 2015). Long-range 
haplotyping will greatly benefit childless de novo mutation carriers, in whom 
linkage analysis cannot be performed. However, the current high cost of these 
sequencing techniques can prohibit their use in routine clinical practice. 
 
 
2.3. Application of single-cell genomics in assisted reproduction   
Over a short period of time single-cell technologies became a standard practice 
for diagnostic laboratories, particularly in the field of assisted reproduction for 
testing preimplantation embryos for genetic abnormalities. Preimplantation 
genetic testing (PGT) of embryos requires the removal of either one or two cells 
from cleavage-stage embryo or a few trophectoderm cells from the blastocyst 
stage, followed by biopsy processing using single-cell technology workflow. 
Alternatively, polar body biopsy of the oocyte can be performed (Fig. 6). In 
case of a blastocyst biopsy, embryos are cryopreserved until the next FET cycle, 
following hormone-supplemented endometrial preparation for embryo transfer. 
Today, PGT can be classified into (i) preimplantation genetic testing for mono-
genic disorders, or PGT-M (previously preimplantation genetic diagnosis), 
(ii) preimplantation genetic testing for aneuploidy, or PGT-A (previously 
preimplantation genetic screening), and (iii) preimplantation genetic testing for 
structural rearrangements, or PGT-SR, designed to help carriers of balanced 
translocations to increase chance of a successful pregnancy, as these couples are 
at increased risk of having a child with unbalanced karyotype. Once the 
necessary analyses are performed, only genetically healthy embryos will be 
chosen for transfer based on the results. In some of countries, especially in 
regions of Asia, PGT can be performed for so-called social sexing, where an 
embryo is selected for transfer based on the gender. In Europe, non-medical 
gender selection is prohibited and sexing can be performed only in case of  
X-linked recessive disorders, when the causal mutation is unknown. 
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Figure 6. Single-cell genomics for preimplantation embryo testing. Preimplantation 
genetic testing is based on direct genetic analysis of embryonic material. During the 
biopsy procedure, either one or two cells are removed at cleavage-stage on day 3 or 5–
10 cells from the trophectoderm at blastocyst stage on day 5–6. Alternatively, polar 
bodies can be biopsied to screen for maternal genetic defects only. Subsequently, 
biopsied material is whole-genome amplified and screened either for inherited 
mutations or for chromosomal imbalances by using appropriate single-cell platform. 
Figure based on (Van der Aa et al., 2013).  
 
 
2.3.1. Preimplantation genetic testing for monogenic disorders 
As an alternative to prenatal diagnosis, patients can be referred to IVF/PGT-M 
to avoid transmitting an inherited genetic disorder that runs in the family to their 
child. The first PGT-M application was done already in 1990 by performing 
sexing of the embryos using PCR to avoid transfer of male embryos, affected 
with an X-linked disorder (Handyside et al., 1990). In the following years, next 
successful PGT-M was reported for cystic fibrosis, based on fragment analysis 
(Handyside et al., 1992). Almost three decades later, PGT-M is performed 
worldwide and includes the analysis against Mendelian hereditary conditions 
with a known cause, including autosomal-recessive, autosomal-dominant and 
X-linked disorders (De Rycke et al., 2017). Traditionally, biopsied cells can be 
analyzed by either single-cell multiplex PCR coupled with short tandem repeats 
(STR) haplotyping (Fiorentino et al., 2006; Harton et al., 2011). However this 
method comes with a bouquet of limitations: they are labor-intensive and 
require time consuming locus- and family-specific probe design. Consequently, 
this could lead extensive service costs and long waiting list, which can cause 
unnecessary emotional stress to couples. In addition, PCR-assays need to 
minimize ADO effect, which is the primary reason for misdiagnosis. The 
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development of single-cell genomics and novel genome-wide approaches, 
addressed earlier, have begun to overcome these limitation (Natesan et al., 
2014; Vermeesch et al., 2016; Dimitriadou et al., 2017).  
From a healthcare perspective, it has been proposed that national IVF/PGT-M 
programs can be implemented into the modern healthcare system, offering free 
service for carrier couples in order to avoid lifetime costs, associated with 
medical treatment of patients affected by the genetic disease. The scope of 
PGT-M has also been expanded and the test can also be offered to couples, 
where one or both partners are carriers of genetic mutations, predisposing to 
cancer (e.g. BRCA1 or APC mutations for breast and colon cancer, respectively) 
(Rechitsky et al., 2002; Spits et al., 2007), or adult-onset disease, such as 
Alzeihmer’s (Verlinsky et al., 2002). Despite some of the ethical and legal 
issues, associated with late-onset disease screening (ASRM, 2013), the number 
of PGT-M cycles for these type of conditions is increasing together with 
controversial HLA-matching, in which PGT is employed to conceive a child, 
who later will become a cord blood or hematopoetic stem cell donor for saving 
an already affected sibling (Kakourou et al., 2018).  
 
 
2.3.2. Preimplantation genetic testing for aneuploidy  
In contrast to PGT-M cycles, where young fertile couples are recruited for 
specific mutation screening, PGT-A has been offered to couples, who are 
burdened with fertility issues due to advanced maternal age, recurrent mis-
carriage,recurrent implantation failure or severe male factor infertility. Because 
embryonic chromosomal aneuploidy significantly contributes to embryo 
implantation failure and spontaneous miscarriage, and is likely to explain the 
low success rate of IVF treatments, PGT-A has been established in many IVF 
centres worldwide to select against embryos with abnormal karyotype. Thus, 
PGT-A has the capacity to prevent adverse IVF and pregnancy outcome and/or 
provide alternatives for IVF treatment, such as use of egg donors, especially in 
women with advanced age (Munne et al., 2005; Lathi et al., 2008; Rubio et al., 
2013; Munne et al., 2016). However, after the development of advanced single-
cell technologies that can screen all 24 chromosomes at once, the topic of PGT-A 
has become quite controversial. The first alarming paper came out in 2009 
demonstrating that 70–80% of human IVF cleavage-stage embryos is made up 
of cells bearing signatures of chromosomal instability (CIN), which is a hall-
mark of tumorigenesis, characterized by an increased rate of whole or segmental 
chromosome aberrations (Vanneste et al., 2009). Further independent studies 
also confirmed this phenomenon (Johnson et al., 2010; Chavez et al., 2012; 
Mertzanidou et al., 2013; Chow et al., 2014), which put the whole rationale of 
PGT-A under question, as high-degree of mosaicism at cleavage-stage, even in 
young fertile patients, may not adequately represent the genomic status of the 
whole embryo. These findings also had a direct clinical significance that 
partially explained why cleavage-stage biopsy lacks improvement in IVF baby-
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take-home rate, as revealed by randomized controlled trials in patients under-
going PGT-A (Mastenbroek et al., 2007; Hardarson et al., 2008; Debrock et al., 
2010). Moreover, cleavage-stage embryos with abnormal cells may also develop 
into normal blastocysts (Northrop et al., 2010), highlighting the complex and 
dynamic nature of human early embryogenesis. Ineffectiveness and potential 
embryo damage associated with cell removal at cleavage-stages of development 
(Scott et al., 2013) raised an important discussion at that time: what’s next for 
PGT-A (Vanneste et al., 2009; Harper et al., 2010)? This question also 
prompted an investigation into novel biopsy strategies. In recent years, genomic 
analysis has shifted towards TE biopsy that is now widely adopted for PGT-A, 
because of the ability to analyze multiple cells of the trophoblast lineage 
without disturbing the inner cell mass that will give rise to the future foetus. TE 
biopsy is also thought to be less harmful to the overall developmental capacity 
of embryos, and currently chromosome analysis from the blastocyst stage may 
provide the most reliable representation of the embryonic genome due to the 
lower impact of mosaicism (Yang et al., 2012; Forman et al., 2013; Scott et al., 
2013; Scott et al., 2013). There is also an important technical aspect, as WGA 
performs better on TE biopsies with 5–10 cells, compared to only one single 
cell derived from cleavage-stage biopsy. In addition, NGS techniques were also 
implemented in PGT-A, proving to be a more sensitive method for aneuploidy 
screening in embryos, because of the ability to reliably detect chromosomal 
mosaicism (Munne et al., 2017; Munne and Wells, 2017). Recently, results of a 
multicenter randomized controlled trial were revealed, demonstrating the 
potential benefit of PGT-A at the blastocyst stage on pregnancy outcomes, 
especially in women with advanced age, using NGS-based aneuploidy screening 
(Munne et al., 2017). However, the implementation of highly sensitive single-
cell sequencing for PGT-A also brought up new challenges, associated with 
chromosomal mosaicism in blastocysts and its effect on subsequent prenatal 
development, as transfer of mosaic embryos can lead to live birth (Greco et al., 
2015). As such, embryonic mosaicism is currently under intense investigation to 
elucidate the impact of mosaic aneuploidies on pregnancy outcome and to pro-
vide proper patient counselling in everyday clinical practice (Fragouli et al., 
2017; Munne et al., 2017).  
Although current techniques for PGT-A enable whole-genome chromosome 
screening of single (or few) cells with high sensitivity and specificity, they 
require a potentially harmful and, in case of TE biopsy, technically challenging 
invasive removal of embryonic cells. Thus, non- or less invasive approaches 
have been explored as an alternative to conventional day 3 or day 5 embryo 
biopsy, including blastocoel fluid sampling and analysis of embryonic cell-free 
DNA (cfDNA) in culture medium. However, up-to-date only a few studies have 
explored these options and most of the data were only recently published with 
either poor or contradicting results for both blastocoel fluid (Perloe, 2013; 
Gianaroli et al., 2014; Tobler et al., 2015; Magli et al., 2016) and cfDNA 
analysis (Shamonki et al., 2016; Xu et al., 2016; Feichtinger et al., 2017; Vera-
Rodriguez et al., 2018). In addition, there are still concerns regarding the true 
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origin of genetic material in blastocoel cavity and in spent media, and whether 
interpretation of the genetic results can be biased due to maternal contamination 
(Hammond et al., 2016). Thus, additional research is warranted for further 
investigation and evaluation of non-invasive approaches for embryo aneuploidy 
screening.  
 
 
3. Chromosomal instability in preimplantation embryos 
One of the first crucial milestones of mammalian embryogenesis is the for-
mation of a blastocyst capable of implantation. Yet as mentioned, the develop-
ment of human IVF embryos is compromised by a high rate of chromosomal 
mosaicism, observed at cleavage-stages. This prompted researches to 
investigate the nature and prevalence of embryonic aneuploidy in greater detail. 
In general, aneuploidy and CIN are envisioned as a “vicious cycle”, where 
single aneuploidy can increase the likelihood of CIN, which in turn drives 
aneuploidy (Potapova et al., 2013). The advent of powerful single-cell 
technologies and time-lapse imaging (TLI) has provided novel insights into 
mechanistic origins of CIN in human preimplantation development (Fig. 7). TLI 
has revealed that chromosome imbalances in IVF embryos are not always 
underlined only by mitotic errors, but are often accompanied by aberrant 
cleavage patterns with or without cellular fragmentation. Atypical cell 
morphokinetics, such as entire blastomere fusion or failure of cytokinesis, 
significantly contribute to genomic instability and can be observed in >50% of 
aneuploid embryos (Hardy et al., 1993; Chavez et al., 2012). Recently, fusion of 
a second polar body was detected by whole-genome haplotyping of 
trophectoderm biopsy derived from human IVF blastocyst (Ottolini et al., 
2015). The persistence of polar body DNA in the embryo until the blastocyst 
stage was rather unexpected, giving the fact that polar bodies typically undergo 
fragmentation after extrusion from the oocyte upon fertilization. 
Different studies on animal models have demonstrated that aneuploidy and 
mosaicism in early embryos are not restricted only to humans, but have also 
been observed in farm animals (Viuff et al., 2000; Zudova et al., 2003; 
Rambags et al., 2005) and non-human primates (Dupont et al., 2009; Dupont et 
al., 2010). In contrast, spontaneous aneuploidy rate in mouse embryos is very 
low, so chromosome segregation errors in mice are usually induced by using 
different inhibitors (Lightfoot et al., 2006; Bolton et al., 2016). Using this 
approach, a recent study in mice investigated the developmental fate of induced 
mosaic aneuploidies and demonstrated that aneuploid cells become 
progressively depleted from the embryo at later stages of development (Bolton 
et al., 2016). This finding together with the fact that mosaic embryos can 
successfully result in live birth of healthy babies in human (Greco et al., 2015) 
challenges the hypothesis that aneuploid embryos are not as developmentally 
competent as their euploid counterparts. At the same time, these observations 
highlight our limited knowledge on the molecular causes and the developmental 
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fate of human embryonic CIN and raise important questions regarding both the 
burden and nature of aneuploidy that can be tolerated throughout the 
development. 
 
Figure 7. Causes of aneuploidy in preimplantation embryos. Different events may 
contribute to the generation of embryonic aneuploidy, such as mitotic and meiotic 
defects, DNA damage, fertilization errors and aberrant cleavage dynamics. Both meiotic 
and mitotic aneuploidy can increase the likelihood of chromosomal instability within an 
embryo. Similarly, aberrant fertilization and impaired cleavage morphokinetics can lead 
to blastomeres with unstable genomes or chaotic chromosome patterns. Adapted by 
permission from (Tsuiko et al., 2018). 
 
 
3.1. Maternal contribution to embryonic aneuploidy 
Genome integrity of the cells strongly relies on intact molecular mechanisms 
involved in accurate chromosome segregation during meiotic and mitotic 
divisions. Errors in either first or second meiotic division lead to zygotic 
inheritance of meiotic-based aneuploidies that can consequently cause spon-
taneous miscarriages, stillbirth or congenital birth defects. Given the complexity 
of meiosis during oogenesis, compared to spermatogenesis, it is not surprising 
that the majority of meiotic errors in the embryo are of maternal origin (Hassold 
and Hunt, 2001). Moreover, the incidence of maternal aneuploidy rises abruptly 
in the mid-thirties and reaches up to 80% by the age of 45 (Franasiak et al., 
2014). As woman ages, her meiotic recombination machinery becomes less 
efficient in time, because it is constantly influenced by the environmental and 
age-related factors that accumulate in the ovary. In turn, this can potentially lead 
to altered genomic recombination patterns, which were suggested to be a risk a 
factor for trisomy 21 (Lamb et al., 2005; Lamb et al., 2005). In general, meiotic 
recombination in oocytes is surprisingly error-prone, as oocytes are inefficient 
in translating DSBs into crossovers, while lower genome-wide recombination 
rates can increase the risk of developing vulnerable crossover configurations 
that can interfere with proper segregation of sister chromatids (Ottolini et al., 
2015; Wang et al.).  
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The considerable time between the initiation and the completion of meiosis 
may also likely contribute to the alteration or degradation of factors important 
for proper chromosome segregation. Numerous morphological and cellular 
defects that occur in the oocyte, especially aged ones, will consequently impact 
fertilization rates and reduce embryo development potential (Miao et al., 2009; 
Keefe et al., 2015). Notably, age-related oocyte aneuploidy is multifactorial, 
originating from diminished cell-cycle regulation, aberrant spindle formation, 
loss of proper checkpoint signalling and compromised centromeric cohesion 
between sisters chromatids [reviewed in (Webster and Schuh, 2016)]. Defective 
spindle assembly can also be attributed to the age-related chaotic microtubule 
dynamics that result in multipolar spindles and predispose the oocyte to 
chromosome segregation errors (Nakagawa and FitzHarris, 2017). This, in 
combination with general oocyte-specific spindle assembly checkpoint (SAC)-
mediated control of meiosis, which is not able to block meiotic progression 
upon misalignment of a single chromosome, results in an increased aneuploid 
egg formation in older women and propagation of aneuploidy to developing 
embryo (Nagaoka et al., 2011). In contrast, male cell-cycle checkpoint 
mechanisms seem to be more robust and can successfully eliminate cells with 
meiotic errors regardless of paternal age (Vrooman et al., 2014). 
One of the reasons for the age-related decrease of cellular functions in the 
oocyte might be the influence of age on oocyte transcriptional activity, neces-
sary to guide cytoplasmic maturation, meiotic divisions and post-translational 
process (Steuerwald et al., 2007; Grondahl et al., 2010). Second, the age-related 
downregulation of protein ubiquitination in the mammalian oocytes can lead to 
breakdown of ubiquitin-proteasome pathway, resulting in failure to support 
meiosis, cell cycle progression and polar body I extrusion (Sun et al., 2004; 
Ben-Eliezer et al., 2015; Yu et al., 2015). The inhibition of proteosomal activity 
can also interfere with maternal clearance in the zygote and impair early 
embryonic development (Shin et al., 2010; Yang et al., 2017). Third, dys-
function of genes and proteins involved in meiotic cell cycle and metaphase 
spindle formation may also partially explain the elevated prevalence of three 
pro-nuclear (3PN) zygotes in older women undergoing IVF or ICSI treatment 
that results from the compromised ability to extrude polar body II (Grondahl et 
al., 2017). Finally, both zona pellucida and plasma membrane of aged oocytes 
undergo structural changes that may likely predispose the aged oocyte to fertili-
zation abnormalities, resulting in either reduced fertilization rates or increased 
incidence of polyspermy due to compromised membrane block to prevent poly-
spermic egg penetration (Wortzman and Evans, 2005).  
The decreased cellular function in the oocyte has also been extensively 
associated with altered mitochondrial biogenesis, morphology and function 
(May-Panloup et al., 2016). Cell division is energy demanding and alterations in 
mitochondrial dynamics and metabolic pathways can impair the process 
(Salazar-Roa and Malumbres, 2017). In support of this, deficit in mitochondria-
produced ATP was shown to cause spindle instability and impaired chromo-
some segregation in MII mouse oocytes (Zhang et al., 2006). Because ATP is 
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required for the movement of microtubules during anaphase and cytoskeletal 
actin filament contraction during cytokinesis, the decreased mitochondrial DNA 
content in the oocytes may fail to synthesise sufficient amount of ATP, contri-
buting to aneuploidy formation in oocytes and future embryos (Wilding et al., 
2001; Eichenlaub-Ritter et al., 2004; Fragouli et al., 2015). Interestingly, embryos 
seem to possess a compensatory mechanism for inherited mitochondrial defi-
ciency by initiating premature mitochondrial biogenesis, however this untimely 
response seems to lead to reduced developmental potential (Fragouli et al., 
2015). Thus, defective maternal resources, together with the relaxed or absent 
cell-cycle checkpoint discussed above, may contribute to embryonic aneuploidy, 
compromising preimplantation development.  
 
 
3.2. Paternal contribution to embryonic aneuploidy 
Up to 80% of chromosome imbalances in IVF human embryos are mitotic in 
origin and lead to chromosomal mosaicism. In case of mitotic mosaicism, male 
factors are often suspected, as increased DNA damage of human spermatozoa 
can negatively impact fertilization rates and/or early embryo development 
(Duran et al., 2002; Benchaib et al., 2003; Silber et al., 2003). Because male 
germ cells divide continuously, DNA lesions start accumulating over time in the 
testis, mostly due to oxidative stress. Failure to repair oxidative DNA damage can 
result in genomic integrity decline in the sperm, especially in males with 
advanced paternal age (Paul et al., 2011). Reactive oxygen species (ROS), along 
with apoptosis and abnormal chromatin packaging, can also lead to sperm frag-
mentation, which is one of the causes of male subfertility and infertility. Sper-
matozoa with fragmented and/or unrepaired DNA are able to fertilize oocytes, but 
they can significantly contribute to the generation of chromosomal aberrations in 
the embryo, compromising its development (Garcia-Ferreyra et al., 2015).  
Aside from providing the paternal genome, sperm cell also contributes its 
centrosome to generate the mitotic spindle that segregates chromosomes to two 
sister blastomeres during the first post-zygotic division (the only exception is 
the mouse, where centrosome is maternally inherited). However, in some 
fertilized oocytes the first post-zygotic cleavage does not occur as expected. 
Under in vitro conditions almost 12% of human zygotes divide into three cells 
(Chamayou et al., 2013). Time-lapse analysis of human IVF embryos has 
revealed that tripolar division is frequent in dispermic zygotes with three 
pronuclei (3PN), carrying an extra set of haploid paternal or maternal 
chromosomes, but bi-pronuclear (2PN) embryos also exhibit abnormal first 
post-zygotic cleavage (Joergensen et al., 2014). Hence, sperm centrosome 
anomalies and formation of abnormal tripolar spindle result in chaotic 
chromosome profiles of the embryo due to disorganized first mitotic division 
(Moomjy et al., 1999; Silber et al., 2003).  
Lastly, in addition to inheritance of centrosome components, several studies 
have implied that sperm retains coding and non-coding RNAs that are necessary 
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for successful fertilization and may be potentially relevant in regulating gene 
transcription and cellular processes in early embryos (Boerke et al., 2007; 
Sendler et al., 2013; Teperek et al., 2016; Selvaraju et al., 2017). However, 
unlike maternal transcripts, the role of RNAs detected in paternal gametes has 
remained uncertain and the impact of aberrant paternal factors on embryo 
genome stability requires further elucidation.  
 
 
3.3. Post-zygotic origins of embryonic aneuploidy 
As embryonic cleavage proceeds, errors in post-zygotic division, such as centro-
some overduplication, impaired spindle assembly, chromosome cohesion/segre-
gation dynamics and cytokinesis, can contribute to chromosome missegregation 
and aneuploidy (Silkworth and Cimini, 2012). Indeed, knockout studies in 
mouse pre- and peri-implantation embryos have revealed that disruptions in key 
genes involved in the centrosome/kinetochore structure or cell-cycle check-
points lead to aneuploidy, mitotic arrest, abnormal mitotic division and early 
embryonic lethality (Artus et al., 2006). Although there are numerous possible 
mechanisms leading to post-zygotic errors in cleavage-stage embryos (Fig. 8), 
anaphase lagging and mitotic non-disjunction are the most frequent causes of 
embryonic aneuploidy and mosaicism. During mitotic non-disjunction, chro-
matids fail to separate at the centromere during cell division, resulting in loss of 
a chromosome in one daughter cell and a reciprocal gain in the other. In contrast 
to chromosome non-disjunction, anaphase lagging occurs when one of the sister 
chromatids fails to connect to the spindle apparatus or is prematurely dis-
sociated from it and is lost upon cytokinesis, resulting in one diploid daughter 
cell and one cell with a monosomy. 
In addition, erroneous merotelic kinetochore-spindle microtubule attach-
ments can also contribute to the onset of aneuploidy and CIN in early embryos. 
Just like in meiosis, spindle assembly and chromosome alignment on the meta-
phase plate during mitosis is regulated by SAC machinery that prevents prema-
ture separation of sister chromatids until proper chromosome alignment has 
been achieved and all kinetochores have established a stable connection to bi-
polar spindles. Once tension is detected, SAC is inactivated, MTs shorten and 
two sister chromatids become separated until finally cytokinesis divides the cell 
into two daughter cells with complementary sets of chromosomes. In correct 
amphitelic attachment, k-MTs attach each sister kinetochore to opposite spindle 
poles, establishing bi-oriented chromosome orientation that is necessary for 
proper chromosome segregation. In merotelic k-MT attachments, single kine-
tochores attach to microtubules extending from both spindle poles. Because 
kinetochores are attached by MTs from both sides and support chromosome 
alignment on a metaphase plate, merotely avoids detection by SAC, which leads 
to failure of chromatid segregation and lag of one chromosome near the central 
spindle, while the other chromosome moves towards the spindle pole 
(Thompson and Compton, 2011). Because merotely is not detected by SAC, it 
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may cause anaphase lag at the spindle equator or centromeric breakage of the 
chromosome, leading to aneuploidy or sub-chromosomal imbalances, respec-
tively. It has been proposed that merotely can also induce centromere-localized 
DNA breaks, leading to sub-chromosomal imbalances that can be accompanied 
by breakage-fusion-bridge (BFB) cycle and/or result in complex genomic 
rearrangements observed in human IVF embryos (Vanneste et al., 2009; Voet et 
al., 2011; Voet et al., 2011). Consequently, the lagging chromosomes can form 
micronuclei in the cytoplasm, providing the basis for cellular fragmentation in 
human embryos (Chavez et al., 2012). Once trapped within micronuclei, 
chromosomes can undergo defective DNA replication, resulting in DNA damage 
and frequent double-strand breaks (DSB) (Crasta et al., 2012). In turn, DSB can 
trigger an error-prone non-homologous end-joining (NHEJ) repair mechanism in 
micronuclei (Ly et al., 2017) that can result in chromosomal aberrations. These 
events may also lead to chromosome pulverization within the micronuclei. 
Moreover, chromosomal fragments can be incorporated back into the genome of a 
developing embryo upon fusion of the micronuclei with blastomeres, resulting in 
chaotic chromosome aberration patterns (Chavez et al., 2012). 
 
 
Figure 8. Schematic overview of post-zygotic events, leading to aneuploidy in 
preimplantation embryos. Adapted by permission from (Mantikou et al., 2012). 
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II. AIMS OF THE STUDY 
The introduction of IVF into clinical practice made it possible to study human 
embryos at their earliest stages of development. The application of single-cell 
genomics revealed that cleavage-stage embryos are burdened with aneuploidy, 
which significantly contributes to implantation failure, first trimester 
miscarriage and low IVF success rate. This knowledge also prompted the 
investigation into novel biopsy and embryo comprehensive chromosome 
screening (CCS) strategies for preimplantation genetic testing for aneuploidy 
(PGT-A). However, some of the post-zygotic events observed in vitro may also 
occur in vivo, as only 30% of human conceptions result in live birth, while in at 
least half of all spontaneous miscarriages chromosomal abnormalities can be 
detected. Owing to considerable legal and ethical limitations, associated with 
human oocyte and embryo research, the possibilities to study genetic and 
molecular features of human embryo development in vivo are lacking. As such, 
the use of appropriate animal models is inevitable to understand the origins of 
embryonic chromosomal instability (CIN) that drives error-prone stages of 
preimplantation development. Ultimately, the overall objectives of the current 
thesis were: 
 
1. To investigate the genomic architecture of in vitro bovine cleavage-stage 
embryos by concurrent haplotyping and copy-number profiling of single 
blastomeres. 
 
2. To investigate the prevalence and nature of CIN in naturally conceived in 
vivo embryos, using the established bovine model for studying genomic 
instability in preimplantation embryos.  
 
3. From the clinical perspective, to investigate the use of blastocoel fluid 
aspiration as an alternative less invasive biopsy approach for obtaining 
embryonic genetic material for PGT-A.  
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III. MATERIALS AND METHODS 
3.1. Donor animals and embryo production protocols 
(Study I & II) 
 
Figure 9. Schematic overview of different embryo production protocols used for 
Study I and II. For Study II, five donor cows were used to obtain in vitro embryos 
produced by ovum pick up with ovarian stimulation (OPU-IVF) (left). Next, naturally 
conceived in vivo embryos were obtained from the same donor cows via oviduct flush 
(middle). Finally, donor cows were slaughtered and in vitro embryos were produced 
from in vitro matured oocytes retrieved without ovarian stimulation (IVM-IVF) (right). 
For Study I, only IVM-IVF embryos from eight donor cows were used for the analysis 
[Fig. 1 in (Tsuiko et al., 2017)]. 
 
The general scheme of different embryo production protocols used in Study I and 
Study II is depicted in Figure 9. Oocytes from eight slaughter house-derived 
Belgian blue cows (Bos taurus) and semen from two Holstein-Friesian bulls 
(Bos taurus) were used for bovine in vitro embryo production (IVP) in Study I. 
Because haplotyping requires parental genotypes for phasing, ovarian tissue from 
donor cows (mothers) and semen from two bulls (fathers) were used to extract 
bulk DNA (DNeasy Blood and Tissue kit, Qiagen, Germany). In addition, bulk 
DNA was obtained from the parents of the bull (parental grandparents).  
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For Study II, five young, healthy, cycling Holstein Friesian heifers (Bos taurus) 
between 18 and 36 months of age were used as oocyte and embryo donors. 
Similarly, blood samples from the donor cows (mothers) and semen from the 
bull (father) were used to extract bulk DNA (DNeasy Blood and Tissue kit, 
Qiagen, Germany). Bulk DNA was also obtained from the parents of the bull 
(paternal grandparents) and the available parents of the cows (maternal 
grandparents). All animal experiments were approved by the Ethical Committee 
of the Faculty of Veterinary Sciences of Ghent University, Belgium 
(EC2013/197, EC2015/71). 
 
 
3.1.1. Stimulation protocol and ovum pick up 
Basic Eagle’s Medium amino acids, Minimal Essential Medium (MEM) non-
essential amino acids (100×), TCM-199-medium, kanamycin and gentamycin 
were purchased from Life Technologies Europe (Ghent, Belgium). All other 
necessary components were obtained from Sigma (Schnelldorf, Germany), 
unless otherwise stated. Before usage, all the media were filter-sterilized 
through a 0.22 μm filter (Pall Corporation, Ann Arbor, MI, USA). 
Stimulation protocol for ovum pick up (OPU) was used to generate OPU-
IVF embryos and was performed 3 to 6 times in all animals with at least one 
week interval between OPU sessions. On day 0, heifers were given an epidural 
anesthesia using 3 mL of Procaine Hydrochloride 2% (VMD, Belgium) to 
decrease peristalsis and discomfort. An ultrasound probe was inserted in the 
vagina, and dominant follicles larger than 5 mm were removed by puncturing 
the ovaries to promote follicular growth. Animals received dinoprost (PGF2α) 
intramuscularly (i.m.) (Dinolytic®, Zoetis, Belgium) and a CIDR (controlled 
internal drug release, Progesterone, Zoetis, Belgium) was administered in the 
vagina. In following days, pFSH injections (Stimufol®, Reprobiol, Belgium) 
were given i.m. twice a day. The CIDR was removed 40 to 44 hours after the 
last pFSH injection and OPU was performed. Prior to OPU procedure, animals 
were given an epidural anaesthesia using 3 mL of Procaine Hydrochloride 2%. 
All follicles were aspirated using an ultrasound probe, a 7.5 MHz transducer 
and a stainless steel guide. Puncturing was performed using disposable 19G 
needles connected to a 50 mL tube via silicon tubing. Needles were changed 
between ovaries of the same animal and between different animals. Follicular 
fluid containing the oocytes was collected in 5 mL HEPES-buffered TCM-199 
supplemented with 18 IU/mL heparin, 50 µg/mL gentamicin and 0.1% fetal calf 
serum (FCS). The collected follicular fluid was immediately filtered through a 
75 µm mesh filter with HEPES-buffered TCM-199. Oocytes were grouped per 
donor and embryos were produced according to the standard in vitro embryo 
production protocol. 
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3.1.2. Bovine in vitro embryo production 
Bovine in vitro embryos were produced per donor by previously described 
methods (Catteeuw et al., 2017). Briefly, oocytes retrieved via OPU procedure 
and oocytes retrieved from ovaries of slaughtered animals were placed per 
donor in 500 µL maturation medium for 22 h at 38.5 °C in 5% CO2 in humi-
dified air. The maturation medium consisted of modified bicarbonate-buffered 
TCM-199 supplemented with 50 µg/mL gentamycin and 20 ng/mL epidermal 
growth factor (EGF). After maturation, frozen-thawed semen of a previously 
tested Holstein Friesian bull was used for fertilization. Spermatozoa were 
separated over a discontinuous Percoll gradient (45 and 90%; GE Healthcare 
Biosciences, Uppsala, Sweden) and sperm concentration was adjusted to 1 × 106 
spermatozoa/mL using IVF-TALP medium, which is supplemented with 
6 mg/ml bovine serum albumin (BSA, Sigma A8806) and 25 μg/ml heparin. 
Matured oocytes were co-incubated with spermatozoa in 500 µL IVF-TALP 
medium for 21h at 38.5 °C in 5% CO2 in humidified air. Presumptive zygotes 
were transferred to synthetic oviductal fluid (SOF) supplemented with essential 
and non-essential amino acids, 0.4% BSA (Sigma A9647) and ITS medium 
(5 µg/ml insulin, 5 µg/ml transferrin and 5 ng/ml selenium) and were placed in 
a droplet of culture medium per donor. The droplet size differed between 
donors, depending on the number of zygotes, maintaining a 1:2 embryo:medium 
ratio. The minimal droplet size was 20 µL. Each droplet was covered by mineral 
oil and incubated at 38.5°C in 5% CO2, 5% O2 and 90% N2. 
 
 
3.1.3. Collection of in vivo-derived bovine embryos by oviductal flush 
The in vivo collection of embryos was performed by oviductal flush, as 
described earlier (Besenfelder et al., 2008). First, oestrous cycles of donor 
animals were pre-synchronized by i.m. administration of 2 ml PGF2α (500 µg 
Cloprostenol, Estrumate, Belgium) twice within 11 days. Forty eight hours after 
both PGF2α treatments, the animals received i.m. 21 µg of Gonadotropin 
Releasing Hormone (GnRH) (Receptal®, MSD AH, Belgium). Dominant 
follicles were ablated nine days after heat detection. Thirty six hours after 
follicle ablation, pFSH was administered in decreasing dosages twice a day for 
four consecutive days (1.5 mL, 1.4 mL, 1.2 mL, 1.1 mL, 0.8 mL, 0.6 mL, 
0.5 mL and 0.5 mL, respectively), and in total 380 µg of follitropine was given. 
The donor animals received two PGF2α treatments 60h and 72h after the initial 
pFSH treatment. Finally, 24h after the last pFSH treatment, 21 µg GnRH was 
administered to induce ovulation; simultaneously animals were artificially 
inseminated (AI) with frozen-thawed semen. AI was repeated 12h and 24h later 
and embryos were flushed bilaterally 36h after the last AI. Briefly, donor 
animals were given epidural anaesthesia using 5 mL of Procaine Hydrochloride 
2% and an embryo flushing catheter was directed through the cervix and fixed 
in the uterine horn. An integrated device, consisting of a universal tube, an 
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endoscope and flushing system was inserted through the vaginal wall into the 
peritoneal cavity, which was passively filled with air. The flushing system 
consisted of a 20 mL syringe, a perfusor tube and a metal tube with numerous 
lateral holes covered by a silicon tube. The curved end of the metal tube was 
inserted via the infundibulum into the ampulla. Oviducts were flushed with 40 
to 60 mL flushing medium, consisting of phosphate buffered saline (PBS), 
supplemented with 1% FCS, to get the embryos pass the uterotubal junction. To 
avoid medium reflux, slight pressure near the flushing tube was applied. Once 
in the uterine horn, flushing medium, containing the embryos, was collected via 
the uterus flushing catheter into an embryo filter. The uterine horn was then 
flushed with another 300 to 500 mL medium through the uterine flushing 
catheter. The whole flushing procedure was repeated for the other oviduct and 
uterine horn. Finally, the collected medium per donor was transferred to Petri 
dishes and examined for embryos under a stereomicroscope. 
 
 
3.2. Single-cell workflow for analysis of bovine  
cleavage-stage embryos (Study I & II) 
3.2.1. Single blastomere isolation and whole-genome amplification 
All obtained bovine embryos were treated with 0.1% pronase (S. griseus, Sigma 
P88110) in Hepes-buffered TCM-199 (Life Technologies Europe, Belgium) to 
dissolve zona pellucida, except for in vivo-derived embryos, where 1% pronase 
solution was used. The zona-free embryos were then washed in HEPES-
buffered TCM-199 with 10% FCS followed by Ca+2/Mg+2 free PBS with 0.05% 
BSA to stimulate blastomere dissociation. Next, each blastomere was washed in 
three droplets of wash medium (Ca+2/ Mg+2 free PBS with 0.1% polyvinyl-
pyrrolidone, PVP) and subsequently transferred into a 0.2-mL PCR tube con-
taining 2 μL of PBS. Blastomere pick-up and tubing was manually performed 
with the use of either mouth-pipette system or the STRIPPER™ micropipetter 
(Origio, Denmark) using 75 µm capillary. The isolated blastomeres were 
immediately snap-frozen on dry ice and stored in –20 °C prior to WGA. The 
DNA from single blastomeres was whole-genome amplified using commercially 
available MDA kits (REPLI-g Single Cell Kit, Qiagen; and GenomiPhiV2, GE 
Healthcare Biosciences™, UK) according to the manufacturer’s protocols. In 
case of REPLI-g Single Cell kit, a fast 3 h protocol was performed according to 
instructions. WGA products were then purified with SPRI-beads (Beckman 
Coulter Inc., USA) at 0.8× total reaction volume. 
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3.2.2. Single-cell SNP-genotyping  
After purification, WGA samples were normalized to 600 ng/µl and bulk DNA 
from the parents and grandparents was normalized to 50 ng/µl prior to the 
downstream use of Illumina Infinium HD assay super protocol, according to the 
manufacturer’s instructions (Illumina Inc.). The WGA and bulk DNA samples 
were genotyped using BovineHD Genotyping BeadChip. Subsequently, the 
discrete SNP genotypes, log-R ratio (logR) and B-allele frequency (BAF) values 
were obtained for each sample by applying the GenCall algorithm, embedded in 
the GenomeStudio software Genotyping Module v.3.1 (Illumina Inc.). SNP 
genotypes were called by setting the GenCall threshold score at 0.75, based on 
the optimization steps described previously (Zamani Esteki et al., 2015). The 
obtained raw logR- and BAF-values, as well as SNP genotypes were applied in 
a modified version of siCHILD computational workflow (siCHILD-bovine) to 
acquire genome-wide haplarithm plots for each sample (as described below).  
 
 
3.2.3. Genome-wide analysis of single bovine blastomeres 
In this research, a newly developed methodology – termed haplarithmisis (Greek 
for haplotypes numbering) – was used to investigate the genome-wide haplo-
type architectures of all single blastomeres, comprising bovine cleavage-stage 
embryos. The step-by-step process of haplarithmisis is depicted in Figure 10 
and is described in greater detail by (Zamani Esteki et al., 2015). Briefly, 
haplarithmisis uses single-cell SNP BAF-values and phased parental genotypes 
to determine genome-wide haplotypes, copy-number state of reconstructed 
haplotypes, as well as the parental and segregational origin of putative 
haplotype anomalies in the cell. First, parental genotypes are phased via SNP 
genotype calls derived from a close relative, e.g. sibling or the grandparents 
(Fig. 10). Next, informative SNP loci are identified, in which case one parent is 
heterozygous and the other parent is homozygous for a particular SNP. These 
informative SNPs are then categorized as paternal, if the father’s genotype is 
heterozygous and mother’s genotype is homozygous, or maternal, when 
mother’s SNP is heterozygous and father’s SNP is homozygous. Next, specific 
combinations of phased parental genotypes are retrieved (P1, P2, M1 and M2; 
Fig. 10) that consequently define single-cell SNP BAF-values. Those BAF-
values, for which called SNPs have a BA genotype in either of the parent, are 
mirrored around the 0.5x axis and all the retrieved BAF-values for consecutive 
SNPs in the genome are segmented and visualized as paternal and maternal 
haplarithm plots (Fig. 11). Importantly, the concept of haplarithmisis also 
enables to detect homologous recombination sites between the parental 
homologs.  
  
Figure 10. The principle of haplarithmisis. The parental genotypes are first phased via SNP genotype calls 
derived from a close relative, after which paternal and maternal homologue 1 (H1) and homologue 2 (H2) are 
determined. Based on the defined phased parental genotype combinations, the SNP–BAF values of a 
blastomere are binned into paternal-informative SNP subcategories P1 (blue box) and P2 (red box); a similar 
approach is used for maternal-informative SNPs to obtain M1 (blue box) and M2 (red box) subcategories. 
When the cell inherits H1 from the father, and either H1 or H2 from the mother, the P1 SNP–BAFs have 
values of either 0 or 1 (corresponding to homozygous AA and BB genotypes in the cell, respectively) and the 
P2 SNP–BAFs have a value of 0.5 (corresponding to heterozygous AB genotypes in the cell). In contrast, 
when the cell inherits H2 from the father, the P1 SNP–BAFs have a value of 0.5 and the P2 SNP–BAFs have a 
value of either 0 or 1. A defined subset of the single-cell BAF values (indicated in orange) are then mirrored 
around the 0.5 axis, allowing to segment single-cell P1 and P2 BAF values for consecutive SNPs in the 
genome. The resulting P1 and P2 BAF segments (depicted in blue and red, respectively) now define the 
haplotype blocks inherited from paternal H1 and H2. The same approach is used to impute maternal M1 and 
M2 BAF-segments. The reconstructed haplotype blocks of the cell, and concomitantly the copy number 
information of these haplotype(s) are then visualised in the parental haplarithm plots. Courtesy of Dr. Masoud 
Zamani Esteki; adapted by permission from https://hiva.esat.kuleuven.be/.  
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Figure 11. Genome-wide haplarithm profile of an individual bovine blastomere. The top row signifies 
different haplarithm profiles for normal disomy, as well as monosomy and trisomy of maternal origin. 
Defined single-cell BAF-values of the segmented P1, P2, M1 and M2, as well as the distance between the 
P1-P2 or M1-M2 denote the origin and nature of copy number (CN) alterations. The normalized logR-
values are integrated with haplarithm profiles for copy-number profiling. The pairwise breakpoints in the 
segmented P1-P2 and M1-M2 in the haplarithm profiles signify homologous recombination sites, 
accompanied by the switch in the haplotype blocks. Based on the recombination patterns, the haplarithm 
signatures also allow tracing chromosomal aberrations back to meiotic I (MI), meiotic II (MII) or mitotic 
segregation errors (with the exception of monosomies). The genome-wide plot is also depicted for a single 
bovine blastomere (bottom), carrying chr3 segmental duplication, chr20 monosomy and chrX nullisomy, 
accompanied by respective changes in the haplarithm patterns and logR ratio. 
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3.2.4 Statistical analysis  
For Study II, statistical calculations were performed using GraphPad Prism 6 
software (GraphPad Software Inc., USA). The prevalence and nature of CIN were 
compared between the three embryo groups and corresponding single blasto-
meres by two-tailed Fisher’s exact test with Bonferroni correction for multiple 
testing. The differences in the frequencies of CIN between the three embryo 
cohorts were considered to be statistically significant when the multiple testing 
corrected P-value was <0.01. When comparing two groups of monospermic 
embryos, a P-value <0.05 was considered to be statistically significant. 
 
3.3. Human embryo biopsy and  
sample processing (Study III) 
Embryo biopsy and sample collection was performed at the Tomsk regional 
perinatal center (Tomsk, Russia) and the Krasnoyarsk Center for Reproductive 
Medicine (Krasnoyarsk, Russia). The study was approved by the Bioethics 
Committee of the Biological Institute of the National Research Tomsk State 
University and all patients have signed an informed consent. All micromani-
pulations were performed under a hood in a high-quality standard IVF labo-
ratory. The schematic representation of study design is depicted in Figure 12. 
Embryo biopsy was performed on cryopreserved blastocysts, donated for 
research by patients, who have undergone IVF treatment. Cryopreservation and 
thawing of blastocysts were done according to the manufacturer’s VT601-TOP/ 
VT602-KIT protocol (Kitazato Corporation, Japan). According to the study 
design, BF was first aspirated, and ICM and TE cells were further isolated and 
collected for separate chromosome analysis. Blastocyst micropuncture and 
aspiration of BF was performed after blastocyst thawing by previously 
described methods (D'Alessandro et al., 2012; Gianaroli et al., 2014). Briefly, 
blastocysts were immobilized by a holding pipette, mounted on a micro-
manipulator, and BF from the cavity of expanded blastocysts was aspirated by 
an ICSI micropipette (Origio, Denmark), which was inserted between the TE 
cells to minimize the possible cell damage. The use of ICSI micropipette also 
minimizes the risk of cross-contamination by intact TE or ICM cells. A single 
aspiration was performed, avoiding aspiration of any cellular material. A 
volume of ~0.01µl of blastocoel fluid was retrieved from each blastocyst, which 
was then expelled into the 2.5 µl of 1x PBS. After BF aspiration and blastocyst 
re-expansion, OCTAX Laser Shot™ microsurgical laser system (MTG, 
Germany) or ZILOS-tk® (Hamilton Thorne, USA) were used to separate TE and 
ICM cells. All biopsied materials were immediately whole-genome amplified 
and stored in –20 °C until further processing. 
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3.3.2. Statistical analysis  
For Study III, statistical calculations were performed using GraphPad Prism 6 
software. The prevalence of chromosomal aberrations, including mosaic 
aneuploidies, in BF, TE and ICM was assessed with Chi-square test and the 
difference in the number of affected chromosomes between diffeent embryo 
biopsies was considered to be statistically significant, when multiple testing 
corrected P-value was <0.002. When comparing the karyotype concordance of 
ICM between either BF or TE, two-tailed Fisher’s exact test was applied to 
determine the potential value of BF-DNA use for aneuploidy screening and P-
value was <0.05 was considered to be statistically significant. 
 
 
Figure 12. The schematic representation of Study III worklow. After initial sample 
collection, the embryonic material was whole-genome amplified and sequencing 
libraries were prepared according to standard VeriSeq™ PGS kit protocol and 
sequenced with Illumina MiSeq® system.  
Inner cell mass biopsy
Trophectoderm biopsy
Blastocoel biopsy
 Whole-genome 
???????????
???????????????
sequencing
??????????????????
?????????????
Cell lysis
????????????? ?????????????????
BF
TE
ICM
3.3.1. Whole-genome amplification and next-generation sequencing. 
Whole-genome amplification of all samples was performed by ligation-
mediated PCR-based commercial PicoPLEX kit according to manufacturer’s 
protocol (Rubicon Genomics, USA). The quality of DNA amplification was 
controlled by 1% agarose gel electrophoresis and the amount of DNA was 
quantified by Qubit® dsDNA HS Assay kit (Thermo Fisher Scientific, USA). 
Next, the most widely used NGS-based platform for preimplantation genetic 
screening (VeriSeq™ PGS, Illumina Inc.) was utilized for embryo chromosome 
analysis. Successfully amplified sample processing and library preparations 
were done according to the manufacturer’s VeriSeq™ PGS kit protocol. The 
obtained libraries were sequenced with Illumina MiSeq® system. Data analysis 
and genome-wide profile visualization was performed by applying standard 
settings on Illumina BlueFuse Multi v4.3 Software with embedded aneuploidy 
calling algorithm. The detection sensitivity and the degree of mosaicism were 
determined by BlueFuse Multi v4.3 numerical values. 
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IV. RESULTS AND DISCUSSION 
4.1. Characteristics of CIN in bovine in vitro  
cleavage-stage embryos (Study I) 
Understanding the mechanism guiding early human preimplantation develop-
ment is the key to implementing potential improvements in ART, as low effi-
ciency of IVF treatments poses significant social and financial burden to the 
patients. However, human embryo research is very restricted due to ethical 
considerations; hence many studies on cellular and molecular mechanisms of 
early embryogenesis inevitably rely on animal models. Historically, the 
relatively cheap mouse model has been the most useful and popular animal model 
for studying biochemical and physiological regulations of mammalian embryo 
development. However, when it comes to studying origins of CIN in early 
embryos, mouse model may be the least suitable due to high genomic stability. 
A major difference between the early human and mouse embryogenesis is the 
timing of EGA. Because mouse embryonic genome is activated already at the  
2-cell stage of development, it can potentially ensure more efficient guarding of 
the genome due to earlier onset of mitotic checkpoints, compared to human 
(Wells et al., 2005; Wei et al., 2011). In addition, human oocytes have a poorer 
competence to maintain genomic stability in embryos prior to EGA, compared 
to mice (Wang et al., 2017). For these reasons, an investigation into a new 
animal model for studying CIN in early embryos was warranted. In contrast to 
mice, EGA in bovine and non-human primates occurs at 8- to 16-cell stage and 
the 6- to 8-cell stage of development, respectively (Graf et al., 2014; Wang et 
al., 2017), which is also accompanied by high levels of aneuploidy, observed in 
these species after IVF (Viuff et al., 2000; Dupont et al., 2009; Dupont et al., 
2010). The upkeep cost of non-human primates is very demanding, but the 
analogies between bovine and human reproduction, including endocrine charac-
teristics, folliculogenesis and live-birth rates per embryo transfer (Malhi et al., 
2005) render the bovine preimplantation embryo as an ideal candidate for 
studying the mechanisms of embryonic CIN in humans. By applying compre-
hensive single-cell genome analysis methodology in Study I, we aimed at 
providing deeper insight into the incidence and nature of CIN in bovine 
cleavage-stage embryos.  
To achieve this goal, we genotyped about 777,000 uniformly spanned SNPs 
across the genomes of 160 single blastomeres derived from 25 in vitro produced 
bovine cleavage-stage embryos, of which 72% (n = 116) were analyzed by 
haplarithmisis following quality control (QC). To determine the genomic 
constitution of embryos, only those embryos were included, in which more than 
half of the blastomeres passed QC (23/25 embryos met this criteria). In our 
cohort, six embryos (26%) were normal diploid in all analyzed cells and 17 
were abnormal (74%), containing at least one blastomere with segmental or full 
chromosome aberration (Fig. 13A-D). Out of 17 abnormal embryos, 15 (88%) 
were mosaic, including four embryos with a mix of normal and abnormal cells 
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(normal/aberrant) and 11 aberrant/aberrant embryos that contained various 
genomic abnormalities in different embryonic cells. A staggering 39% (9/23 
embryos) also had blastomeres burdened with full genome anomalies, including 
genome-wide loss of heterozygosity, UPDs, triploidy, tetraploidy and haploidy. 
For these embryos, single-cell haplarithm profiles and parental haplotypes un-
covered the presence of only paternal (androgenetic) or only maternal (gyno-
genetic) genomes in a single blastomere and enabled triploid blastomeres to be 
classified as diandric or digynic in origin (some of these embryos will be 
discussed in greater detail in Chapter 4.2). Among the embryos with blasto-
meres affected by whole-genome anomalies, one contained only maternal 
genome in all the cells, indicating a parthenogenetic activation of the oocyte 
without any paternal contribution. 
 
 
 
Figure 13. The frequency and nature of chromosomal instability in bovine 
cleavage-stage embryos. (A) General characteristics of bovine embryos based on their 
genomic constitution, including the (i) proportion of normal diploid and abnormal 
embryos and (ii) proportion of abnormal mosaic and non-mosaic embryos. (B) The 
mechanistic origin (i) and nature (ii) of identified whole-chromosome imbalances. 
(C) The frequency and nature of segmental imbalances. (D) The proportion of embryos 
with different genetic anomalies [Fig. 1 in (Destouni et al., 2016)]. 
 
 
In abnormal embryos without uniform ploidy changes, whole-chromosome 
abnormalities were the most frequent errors that included losses (monosomies 
and nullisomies), gains (trisomises, tetrasomies) and uniparental disomies 
(12/23 embryos, 52.17%; Fig. 13D). Whole-chromosome meiotic errors were 
encountered only in 19% of embryos, in which case embryos showed the same 
chromosomal aneuploidy in all sister blastomeres. The rest of whole-chromo-
some imbalances were mitotic in origin (81%, Fig. 13B). Whole-chromosome 
losses, which had a reciprocal duplication in a sister blastomere, represented 
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15% of the mitotic numerical chromosome aberrations that can be explained by 
mitotic non-disjunction, in which one sister cell receives an extra chromosome, 
while the second sister cell loses the same chromosome. The majority of mitotic 
chromosomes are, however, neither reciprocal nor recurrent (42%) in sister 
blastomeres. Such losses of chromosomes are likely due to merotelic 
attachments of microtubules to kinetochores that lead to mitotic anaphase 
lagging and exclusion of one of the chromatids from both sister blastomeres. 
Whole-chromosome gains entail trisomies, tetrasomies and >4 copies of the 
genome, which represent 26%, 3% and 1% of all mitotic numerical chromo-
some anomalies, respectively. Non-reciprocal gains account for 13%, however 
reciprocal losses may be present in sister blastomeres that were not included in 
the analysis due to suboptimal quality.  
The identified segmental abnormalities were classified as simple segmental 
aberrations and complex segmental aberrations. Terminal deletions, terminal 
duplications, terminal amplifications and proximal duplications were termed 
simple segmental aberrations. Of the simple segmental aberrations, 37.5% are 
reciprocal, meaning that they have a terminal deletion in one blastomere and a 
terminal duplication with the same breakpoints on the same allele in the sister 
blastomere. Recurrent segmental imbalances (37.5%) entail only terminal losses 
(Fig. 15C). In contrast, terminal imbalances coexisting with other segmental 
aberrations for the remaining part of the chromosome were labelled complex 
aberrations that represented 47% of all segmental aberrations. Out of complex 
rearrangements, signatures characteristic of breakage-fusion-bridge (BFB) 
cycles were detected in three (13%) of embryos [see also Fig. 2 in (Destouni et 
al., 2016)].  
In summary, haplarithmisis revealed a plethora of genomic abnormalities in 
bovine cleavage-stage embryos, some of which can be missed by conventional 
single-cell DNA copy-number profiling methods [see Supplementary Fig. S1A-B 
in (Destouni et al., 2016)]. The data presented in Study I indicates that incidence 
and nature of CIN in bovine embryos following IVF is similar to what has been 
previously observed in human IVF embryos (Vanneste et al., 2009; 
Mertzanidou et al., 2013; Chow et al., 2014). Hence our study proposes that 
bovine cleavage-stage embryo is a valuable model for providing novel insight 
into the mechanisms of CIN, including in in vivo early embryogenesis. 
 
 
4.2. Spontaneous parental genome segregation  
in the zygote (Study I) 
As uncovered by previous studies in humans and our study in bovine, a variety 
of post-zygotic events, such as mitotic non-disjunction, anaphase lagging, BFB 
cycles and cellular fusions, can contribute to the generation of mosaic embryos 
during early embryogenesis. Surprisingly, by using haplarithmisis that com-
bines haplotype and copy number information, we unexpectedly disclosed for 
the first time that zygotes can segregate entire parental genomes into separate 
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cell lineages that persist and proliferate independently during embryo post-
zygotic cleavages, providing basis for mixoploidy and/or chimaerism formation 
(Fig. 14). Aberrant parental genome segregation was not only triggered by 
abnormal fertilization, but was also evident in monospermic embryos. We 
termed this phenomenon “heterogoneic cell division” (Greek for different 
parental origin). The discovery of heterogoneic segregation adds to the remark-
able genome plasticity of mammalian cleavage-stage development and will be 
discussed in the following chapters. 
Figure 14. The discovery of heterogoneic division in bovine cleavage-stage 
embryos. The figure illustrates simplified genomic representation of single blastomeres 
in embryos after normal and abnormal segregation of parental genomes. In normal 
scenario, the first post-zygotic cleavage results in diploid daughter blastomeres carrying 
both maternal (pink) and paternal (blue) genomes that give rise to biparental cells (top). 
In case of dispermy-induced heterogoneic division, extra paternal genome creates a 
separate androgenetic cell lineage (green) that persists over embryonic cell cycles 
together with biparental blastomeres (middle). Spontaneous genome segregation can 
also occur after normal fertilization, resulting in embryonic cell lineages with only 
maternal or only paternal genomes that co-exist with biparental cells. 
 
 
4.2.1. Heterogoneic division in abnormally fertilized embryos  
As mentioned earlier, haplarithmisis revealed a number of embryos that were 
burdened with genome-wide anomalies. In five embryos (5/23, 22%) an aberrant 
inheritance pattern of paternal haplotypes was observed. In these embryos, 
different cells presented with two different homologous recombination sites on 
the paternal genome, indicating dispermic fertilization (Fig. 15). Remarkably, 
none of these dispermic embryos were uniformly triploid, as one might expect, 
Oocyte
Normal genome 
??????????
Dispermy induced 
heterogoneic division
Heterogoneic division
 in the absence of 
??????????????????
???????????
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but rather contained cells with different numerical ploidy states and different 
parental genome contributions across the blastomeres of the same embryo. 
Moreover, in all dispermic embryos, one of the two paternal genomes was always 
segregated into a separate androgenetic cell lineage, carrying only a set of 
paternal chromosomes. An extraordinary example of genome dynamics can be 
seen in dispermic embryo E16_BRP011, consisting of three androgenetic cells 
with one paternal genome, one compound androgenetic cell with two different 
paternal genomes, two tetraploid cells with 3paternal:1maternal allelic ratio and 
two biparental diploid blastomeres [see Supplementary Fig. S1A-B in (Destouni 
et al., 2016)]. Consistent with our findings, mixoploidy and chimaerism have 
also been observed in human dispermic IVF embryos (Kola et al., 1987; Munne 
et al., 1994; Staessen and Van Steirteghem, 1997); however the allocation of 
different genomes into distinct blastomeres has never been demonstrated before. 
Although it is not surprising to see diandric triploid cells in dispermic embryos, 
one embryo also contained digynic triploid cells with an additional set of 
maternal alleles genome-wide [see Fig. 4 in (Destouni et al., 2016)]. The 
existence of digynic cells in dispermic embryo can be a result of either non-
extrusion of the second polar body or its re-absorption back into the zygote or 
blastomere. Interestingly, the same embryo’s androgenetic cells share chromo-
some abnormalities on Chr 12 (including BFB signatures), Chr 15 and Chr X, 
indicating that these blastomeres arose from a common progenitor.  
 
 
4.2.2. Heterogoneic division in the absence of fertilization errors 
Our data demonstrated that in dispermic embryos, extra set of paternal genome 
was always segregated into highly proliferative androgenetic blastomere lineage. 
Most intriguingly, we also encountered spontaneous genome segregation in two 
embryos that showed no signs of dispermy or digyny. For instance, embryo 
E19_BRP012 represents a remarkable example that further breaks down 
dogmas of cell division, by which daughter cells inherit both parental genomes. 
Namely, this particular embryo contained four androgenetic, four gynogenetic 
and three biparental blastomeres (Fig. 16). Mitotic errors on Chr 9, Chr 14, Chr 
22 and Chr 24 were observed only in one biparental blastomere, but reciprocal 
losses may potentially exist in the cell that could not be analyzed. Second embryo 
E19_BRP005 also contained one gynogenetic, three androgenetic and two 
biparental blastomeres [see Supplementary Fig. S1A-B in (Destouni et al., 2016)]. 
Additional copy-number anomalies were detected on Chr 9, in which case the 
maternal allele was lost in gynogenetic blastomeres and instead was detected in 
androgenetic blastomeres, restoring the diploid biparental state for this chromo-
some. Similarly, androgenetic copy-number aberrations in androgenetic cells, 
affecting Chr 3, Chr 5 and Chr X, had a reciprocal change in biparental cells. 
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4.2.3. How can heterogoneic division occur in early embryos? 
Currently, it remains unclear, how a complete parental genome can be segregated 
to form distinct cell lineages. Ideally, during the zygotic division, the operating 
mitotic spindle segregates chromosomes to two sister blastomeres. Tricho-
tomous division directly into three cells is frequent in diandric or digynic zygotes 
with three pronuclei (3PN), carrying either an extra set of haploid paternal or 
maternal chromosomes, respectively (Staessen and Van Steirteghem, 1997; 
Joergensen et al., 2014). Hence, the simplest explanation for spontaneous parental 
genome segregation would be the direct division of the zygote into three 
blastomeres, resulting in different ploidy and genomic constitution of cells. In 
somatic cells, multiple mechanisms of aberrant division patterns have been 
proposed, including centrosome overduplication, which may produce super-
numerary spindle poles that lead to tripolar cellular division (Maiato and 
Logarinho, 2014). Because the zygote is not an average somatic cell, but rather 
a unique entity, different zygotic stage-specific mechanism might be driving 
trichotomous division. Similarly to human, the first mitotic spindle in bovine 
zygotes is organized by paternally inherited centrosomes (Navara et al., 1994; 
Sathananthan et al., 1996; Sathananthan, 1998); therefore the heterogoneic 
divisions in case of dispermy can potentially result from an operation of two 
independent astral spindles, where one spindle organizes a diploid metaphase, 
and a second ectopic spindle organizes an additional haploid metaphase (Navara 
et al., 1994). Such atypical metaphase plate organization, which is most likely 
accompanied by karyogamy failure, would provide mechanistic basis for sepa-
ration of haploid chromosomes during the zygotic cytokinesis, leading to gene-
ration of two cells lines: androgenetic and biparental (Fig. 17B). Triploid 
embryos can also potentially exclude one haploid genome from metaphase plate 
and allocate extra paternal pronucleus into a distinct lineage through non-
canonical cytokinesis. This mechanism can be corroborated by the observation 
of pronuclear extrusion, which was originally described as the potentially 
haploid third cell-like structure, during the first cleavage of human triploid 
zygotes (Kola et al., 1987; Pieters et al., 1992).  
More intriguingly, heterogoneic division was not exclusive only to abnormal 
fertilization events, as also monospermic embryo contained androgenetic, 
gynogenetic and biparental blastomeres. Similarly to dispermic embryos, we 
envision that the zygote has undergone trichotomous division, generating three 
distinct cell lineages (Fig. 17C-D). This hypothesis seems to be supported by 
the preliminary results of our pilot study, in which bovine IVF embryos were 
time-lapse monitored and individual blastomeres, derived from abnormally 
cleaved embryos, were analyzed immediately after the first post-zygotic division. 
Indeed, we have encountered evidence that aberrant first cleavage underlines 
spontaneous parental genome segregation (unpublished data); however the 
frequency and the precise cellular and molecular mechanisms of this pheno-
menon remain unknown. 
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Figure 17. Hypothetic origins of heterogoneic cell division. (A) In a normal case scenario, the zygote 
undergoes post-zygotic mitotic division into two diploid sister blastomeres, each containing both maternal 
and paternal genomes. (B) After dispermic fertilization, extra paternal genome gets extruded into a separate 
androgenetic lineage, following pronuclear extrusion or ectopic metaphase formation. (C) Normal 
fertilization, followed by parental genome segregation into distinct lineages due to (D) abnormal spindle 
formations or stochastic allocation of parental genomes as a result of non-symmetric cytokinesis. [Fig. 6 in 
(Destouni et al., 2016)]. 
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One hypothetical cause could be the development of gonomeric spindle, driven 
by asymmetric k-MT dynamics between parental genome, which underlies the 
emergence of blastomeres with distinct genomic content (Fig. 17D). Also, the 
co-existence of barrel-shaped meiotic spindle with an ectopic astral spindle 
around chromatin structures has been previously observed in so-called “silently 
fertilized” oocytes (Van Blerkom et al., 2004). Hence, the heterogoneic division 
of the zygote can also be a consequence of simultaneous operation of sperm 
centrosome-mediated spindle together with residual meiotic spindle that was not 
eliminated during oocyte-to-embryo transition. In this case, independent 
coordinated activity of the two spindles can result in direct cleavage into four 
mononucleated blastomeres, containing either maternal or paternal DNA (Fig. 
17D). Finally, the stochastic allocation of parental nuclei to different blasto-
meres through non-canonical cytokinesis might also occur in a zygote, where 
both maternal and paternal pronuclei replicate, but fail to reach karyogamy. 
 
 
4.3. Characteristics of CIN in naturally-conceived  
bovine embryos (Study II) 
Humans are rather inefficient in reproduction and it might take time even for 
healthy fertile couples to conceive a baby. It was estimated that only 30% of 
natural conceptions result in live-birth and the majority of embryos are lost 
already during early stages of pregnancy (Macklon et al., 2002). As mentioned 
previously, embryonic aneuploidy is one of the leading factors of human 
reproductive wastage, and chromosome aberrations can often be detected in 
spontaneous abortion cases (Menasha et al., 2005; Levy et al., 2014). In 
addition, submicroscopic terminal deletions, duplications and isochromosomes 
are often detected in newborns (Riegel et al., 2001), and several cases of mosaic 
individuals, exhibiting chimaerism and mixoploidy have also been well 
documented (Jarvela et al., 1993; Edwards et al., 1994; van de Laar et al., 2002; 
Yamazawa et al., 2010). Intriguingly, traces of triploid, diploid and haploid cell 
lineages have been observed in these reported individuals. Finally, complete 
hydatidiform moles of androgenetic origin have also been described in both 
human (Ibrahim et al., 1989; Kwon et al., 2002; Sun et al., 2012; Obeidi et al., 
2015) and in cattle (Meinecke et al., 2002). These observations, together with 
relatively low overall human fecundity, led us to investigate, whether CIN can 
also be inherent to in vivo embryogenesis. As naturally conceived human 
embryos are not available for research, CIN in human IVF and in vivo embryos 
cannot be compared directly. Alternatively, animal models have been used to 
investigate chromosomal abnormalities in in vivo preimplantation embryos 
(Viuff et al., 2001; Rambags et al., 2005; Coppola et al., 2007). The major 
limitation of these studies is the application of low-resolution traditional 
karyotyping methods that can neither detect submicroscopic changes nor 
determine the nature of genomic anomalies at a single-cell level. Hence, the 
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knowledge about the stability of naturally conceived embryos remained limited, 
largely due to the lack of robust genome analysis technologies.  
In Study I, we have demonstrated that chromosome instability is conserved 
between human and bovine cleavage-stage embryos following IVF, making 
bovine a valuable animal model for studying CIN in early embryos. Equally 
important, gestational period of cows is nine months and only 40–55% of dairy 
cows produce an offspring after single insemination (Diskin et al., 2012). 
Although aneuploidy was reported in 22% of bovine aborted foetuses and 
neonates (Coates et al., 1988), this number might be an underestimate, as most 
of the studies in cattle were done at late gestational period, while whole-
chromosome losses or gains are usually lethal already during the first trimester 
(Schmutz et al., 1996). Therefore, we have continued our studies using bovine 
as a model to investigate chromosome instability in naturally conceived 
embryos. We have used the same approach, as in Study I: all single blastomeres 
of embryos were isolated, genotyped using Illumina SNP-array technology and 
analyzed by haplarithmisis. In parallel, as depicted in Fig. 9 (Materials and 
Methods), we tested in vitro produced embryos, derived from in vitro matured 
and fertilized oocytes that were retrieved from the same donor animals after 
ovarian stimulation and ovum pick up (OPU-IVF embryos); and in vitro 
produced embryos, derived from in vitro matured and fertilized oocytes that 
were retrieved from donor animals without ovarian stimulation (IVM-IVF 
embryos). After sample collection and quality control, 171 out of initially 222 
isolated blastomeres (77%) were considered for further analysis and data 
interpretation: 66 blastomeres from 13 IVM-IVF embryos, 46 blastomeres from 
13 OPU-IVF embryos and 59 blastomeres from 16 in vivo-derived embryos. To 
date this is the first study that used single-cell approach to simultaneously 
compare three different settings of embryo production and development and to 
establish a comprehensive spectrum of chromosomal aberrations in single 
blastomeres of in vivo-derived embryos. 
 
 
4.3.1. In vitro procedures exacerbate CIN  
in bovine cleavage-stage embryos 
We first aimed to assess the prevalence of chromosomal abnormalities in IVM-
IVF, OPU-IVF and in vivo-derived embryos. In contrast to our initial hypo-
thesis, the number of abnormal embryos, carrying at least one blastomere with a 
full or segmental chromosomal aberration, increased from 18.8% in in vivo-
derived embryos (3/16) up to 84.6% in IVM-IVF embryos (11/13) (Fig. 18A). 
At the same time, this result may not have been unexpected, as it was com-
parable to the previously published work on cattle, where 7% of naturally con-
ceived embryos were chromosomally abnormal on day-2 post fertilization 
(Viuff et al., 2000). However, when we looked at the chromosome segregation 
patterns at a single-cell level, the difference between the three embryos groups 
became even more staggering, as genomic stability of in vitro embryos was 
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extremely compromised, compared to in vivo-derived embryos (in both cases 
P<0.0001, Fisher’s exact test; Fig. 18B). For this comparative analysis blasto-
meres were scored as balanced, if they did not contain any whole-chromosome 
or segmental anomalies. However, to avoid bias in representing chromosome 
segregation dynamics in single cells, blastomeres with uniform genome-wide 
ploidy state (e.g. fully haploid or triploid cells) were also scored as balanced, 
unless they had additional signatures of chromosomal losses and gains.  
 
Figure 18. The rate of CIN in IVM-IVF, OPU-IVF and in vivo embryos. The 
numbers above the columns represent the total numbers of analyzed embryos (A) and 
blastomeres (B). Statistical difference between different groups has been calculated 
using two-tailed Fisher’s exact test for multiple testing. (A) The proportion of normal 
diploid embryos and aberrant embryos in IVM-IVF (n = 13), OPU-IVF (n = 13) and in 
vivo group (n = 16)., two-tailed Fisher’s exact test for multiple testing. (B) The 
comparison of balanced and unbalanced blastomeres represents the chromosome 
dynamics of single blastomeres in IVM-IVF (n = 66), OPU-IVF (n = 46) and in vivo-
derived embryos (n = 59). **P < 0.01; ***P < 0.001; ****P < 0.0001. [Fig. 2 in 
(Tsuiko et al., 2017)]. 
 
In general, whole-chromosome aneuploidy was the most frequent type of error 
and it was observed in all abnormal in vivo, OPU-IVF and IVM-IVF embryos 
(at a rate of 18.8%, 69.2% and 84.6%, respectively). Segmental imbalances 
were also detected in all three embryo groups, hower they were the most 
prevalent in IVM-IVF embryos (9/13, 69.2%) when compared to OPU-IVF 
embryos (2/13, 15.4%, P = 0.01, Fisher’s exact test) and in vivo embryos (1/16, 
6.3%, P = 0.001, Fisher’s exact test) [see also Fig. 3 in (Tsuiko et al., 2017)].  
We then assessed the level of mosaicism in embryos containing chromo-
somally abnormal cells. The most common mosaic pattern for in vivo and OPU 
embryos was combination of diploid and aneuploid cells that mainly affected 
one pair of chromosomes. In contrast, almost all abnormal IVM-IVF embryos 
were burdened with mixoploidy that can be attributed to a high number of 
abnormally fertilized cases observed among this particular group (69.2%, 9/13). 
Also here dispermic embryos underwent heterogoneic division, where one of 
the extra paternal genomes segregated into a separate androgenetic cell line 
carrying only paternal DNA. For example, three abnormally fertilized embryos 
had separate androgenetic cell lineages, as well as biparental blastomeres 
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(E12_Cross8301, E10_Cross4770 and E06_Cross4006), while the other three 
embryos (E13_Cross8301, E08_Cross4770 and E09_Cross4770) also contained 
triploid blastomeres (Fig. 19). 
 
 
 
Figure 19. Examples of embryos, containing blastomeres with abnormal ploidy. 
The stacked bar plots depict the number of blastomeres with different genomic 
anomalies per embryo. Blastomeres with normal karyotype and with single aneuploidies 
and/or segmental losses or gains that have both maternal and paternal alleles present in 
their genome (diploid embryos) are depicted in black [see also Fig. 3 (Tsuiko et al., 
2017)]. 
 
Intriguingly, although the genome of in vivo embryos is more stable than of 
their OPU-IVF or IVM-IVF counterparts, haplarithmisis revealed one in vivo case 
(E06_Cross9617), in which the zygote most likely also underwent a hetero-
goneic cell division (Fig. 19). This in vivo-derived embryo consisted of three 
diandric triploid cell lines and one gynogenetic line. In addition, based on the 
haplarithmisis, there was no evidence of polyspermy or meiotic errors, sug-
gesting that genome segregation occurred after monospermic fertilization and in 
our case the division of the zygote into three daughter blastomeres could have 
given rise to gynogenetic, biparental and androgenetic cell lines. Subsequently, 
the androgenetic blastomere could have fused with the biparental one, creating a 
diandric triploid that was detected during the analysis. Unfortunately, because 
three out of seven blastomeres could not be analyzed, the genomic constitution 
of these blastomeres remained unknown and the existence of a pure andro-
genetic lineage could not be excluded. Still, our observation does point to a 
common genome segregation mechanism that operates regardless of in vitro or 
in vivo environment, bypassing the developmental selection barrier and possibly 
explaining the origin of human mixoploid and chimeric individuals. Neverthe-
less, together our findings suggest that even though CIN is also present in in 
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vivo embryos, in vitro procedures, such as in vitro maturation, fertilization and 
culture, influence the rate and nature of embryonic chromosomal abnormalities 
and consequently impede embryo developmental potential.  
Finally, because dispermy might influence chromosome missegregation in 
embryos, we then analyzed only those embryos that developed from mono-
spermic zygotes. For this purpose, we combined monospermic IVM-IVF (n = 4) 
and OPU-IVF (n = 12) embryos into a single group (referred to as in vitro) and 
compared them to in vivo-derived embryos (n = 16). The CIN rates confirmed a 
considerable difference between the in vitro produced and cultured embryos, 
and in vivo-derived embryos (10/16, 62.5% vs 3/16, 18.8%, P = 0.03, Fisher’s 
exact test; Supplementary Fig. S2 in (Tsuiko et al., 2017)). In addition, it was 
clear that in vitro procedures can have a negative impact on CIN, when we 
compared the low frequency of chromosomal aberrations and aberrant ploidy 
states in blastomeres of in vivo-derived embryos (7/59, 11.9%) with the high 
frequency chromosomal aberrations and aberrant ploidy states of in vitro 
produced and cultured embryos (27/57, 47.4%, P < 0.0001, Fisher’s exact test). 
This trend persisted even when we removed some of day-3 p.i. embryos to unify 
our cohorts, in which case seven day-2 p.i. in vitro embryos were classified as 
abnormal (7/11, 63.6%, P = 0.04), while the total number of abnormal 
blastomeres in the in vitro group reached up to 45.9% [17/37, P < 0.001, 
Fisher’s exact test; Supplementary Fig. S2 in (Tsuiko et al., 2017)]. 
 
  
4.3.2. The relevance of bovine embryo data  
in the context of human IVF  
Despite the progress made in clinical and laboratory ART protocols, including 
embryo selection for transfer, the pregnancy rate per single IVF cycle still 
lingers at around 30% worldwide (Dyer et al., 2016). The two main factors that 
determine the IVF outcome are the embryonic aneuploidy and endometrial 
receptivity, and here we focus on the former. Studies on early human embryo-
genesis are restricted due to ethical and legal concerns, so unavoidably researches 
must rely on appropriate animal model. Of course, often data obtained from 
model organisms cannot be directly translated to human and caution should be 
applied when doing so, but animal models do provide a valuable insight into a 
wide range of issues at the forefront of human reproductive health and medicine, 
including assisted reproduction. In our case, we demonstrated that the genomic 
stability of in vivo embryos is significantly higher compared to OPU-IVF and 
IVM-IVF embryos. The use of bovine model revealed that CIN is present in 
less than 20% of in vivo embryos compared to at least 70% in in vitro embryos, 
which means in vivo-conceived embryos are most likely more viable. The major 
limitation of the current work is the small number of embryos analyzed, thus 
more studies are warranted to corroborate our findings. Still, the observation 
that in vitro embryos are genetically compromised draws attention to the fact 
that potentially adverse effect of different in vitro procedures and culture on 
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early embryonic development must not be overlooked. If a negative impact of 
different embryo production protocols on embryonic genome integrity was 
observed in cattle, there is no guarantee that it will not be the same for human. 
During preimplantation embryo culture in vitro, even minor alterations in culture 
conditions and micromanipulation of oocytes and embryos may impact embryo 
quality and its subsequent development (Rizos et al., 2002; Wale and Gardner, 
2016). Although it was recently demonstrated that abnormal cells get depleted 
during preimplantation development, there needs to be a sufficient proportion of 
normal cell within the embryo to ensure its survival (Bolton et al., 2016). 
Unfortunately, in vitro culture conditions can exacerbate embryonic aneuploidy 
and reduce this chance of survival, in turn leading to reduced IVF success rate 
per single cycle. This knowledge can be especially relevant, taking into account 
that the number of women voluntarily or involuntarily delaying motherhood is 
also steadily increasing, and for those women, fertility preservation and IVF 
procedures are becoming a mainstream approach to achieve motherhood 
(Lallemant et al., 2016). For these reasons, our results on genomic constitution 
of in vitro and in vivo bovine embryos have two major implications for human 
assisted reproduction: (i) directing individuals towards IVF programs should be 
done cautiously, as it may compromise embryo quality and consequently bring 
great deal of psychological distress to patients and (ii) improvements in the 
embryo in vitro environment are likely still possible to enhance ART/IVF 
success rate. Importantly, any modification to IVF culture conditions should be 
closely monitored under full transparency to avoid inconclusive and/or 
controversial outcomes (Chronopoulou and Harper, 2015). 
This study also indirectly touches the subject of controlled ovarian stimu-
lation. In our study, donor cows underwent hormonal stimulation to increase the 
number of in vivo-derived embryos via oviduct flush, so, unfortunately, these 
embryos do not fully represent the natural conception. Donor cows also 
received hormonal stimulation prior to OPU. Hence, both in vivo-derived and 
OPU-IVF embryos were retrieved after hormonal stimulation of donor animals, 
but we observed more chromosomally balanced diploid embryos and blasto-
meres in in vivo-derived embryos than in OPU-IVF embryos. This indicates that 
in vitro fertilization and culture are the major causes of embryonic aneuploidy, 
rather than ovarian stimulation itself. Because there is still an ongoing debate on 
the potential deleterious effect of ovarian stimulation on oocyte and embryo 
quality, more studies should be conducted on this matter; however based on our 
data, the effect of hormonal stimulation is expected to be minor. 
Finally, we contribute to understanding why IVM of human eggs and sub-
sequent in vitro fertilization and embryo culture are associated with low 
reproductive success. When oocytes are matured in vivo, they originate from 
ovulatory follicles that undergo strongly regulated processes of selection, growth 
and dominance. In contrast, oocyte IVM can perturb proper nuclear (spindle 
organization, chromosome segregation) and cytoplasmic maturation that is 
necessary for normal fertilization and oocyte-to-embryo transition (Combelles 
et al., 2002; Li et al., 2006; Nichols et al., 2010). As reviewed earlier, the oocyte 
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plays a central role in maintaining genomic integrity before the major EGA 
wave and first post-zygotic divisions are highly dependent on the large pool of 
maternal mRNAs and proteins acquired by the oocyte during maturation. In 
light of this, the inherited aberrant transcriptome has been associated with 
altered first cleavages in human embryos, highlighting the importance of 
maternal factors on early embryonic development (Vera-Rodriguez et al., 2015). 
Therefore, in the current study, the higher rate of chromosomal abnormalities in 
IVM-IVF embryos likely arises from the defective maternal resources in the 
oocyte; however more research should target the precise impact of the intrinsic 
quality of the oocyte on the incidence of chromosomal aberrations in cleavage-
stage embryos. We also add another note of caution with respect to the use of 
human oocyte IVM. Namely, in human IVM procedure, subsequent oocyte 
fertilization is typically performed by ICSI, but traditional IVF (human IVM-
IVF) has also been proposed as a better alternative to fertilize in vitro-matured 
oocytes (Soderstrom-Anttila et al., 2005; Walls et al., 2012). However, the 
IVM-IVF combination may not be beneficial for humans, because in vitro-
matured oocytes have no contact with the oviductal fluid, and thus zona 
pellucida of IVM oocytes may become less resistant to dispermic fertilization 
under in vitro conditions (Xia, 2013). Our results seem to corroborate this view, 
as dispermic fertilization was almost exclusively found among IVM-IVF 
embryos. Of course in humans, the presence of polyspermy can be detected by 
checking the number of pronuclei, which is not possible in bovine zygotes 
because of the dense lipid content. However, it would also likely imply that a 
number of embryos will be immediately discarded and not considered for 
transfer due to abnormal PN status, reducing the total number of healthy 
embryos. Currently, suboptimal human IVM outcome is the main reason why 
oocyte IVM is rarely used in clinical practice, but nevertheless the technology is 
promising, especially for a subset of patients (e.g. PCOS or oncology patients), 
and the attempts to improve IVM protocols and conditions are still ongoing. 
To sum up, bovine data presented here highlights important genomic aspects, 
associated with in vitro maturation, fertilization and culture, although excessive 
generalization between bovine and human should be avoided. However, in the 
absence of human data, ART should foremost be proposed to those couples who 
have a medical indication for IVF treatment, while the use of IVF for social 
reasons should be critically discussed, taking into account possible compli-
cations associated with assisted reproduction. If ART is to be an integral part of 
modern society, decision making on treatment strategies should also carefully 
consider all possible risks to avoid low implantation rates and/or undesired 
pregnancy outcomes. 
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4.4. Blastocoel fluid as a source of DNA for PGT-A (Study III) 
Together with improvements in IVF laboratory protocols, technological advances 
in single-cell genomics also push the boundaries of PGT-M and PGT-A to 
enable faster and more efficient genetic analysis. PGT-A has been implemented 
into the clinics to tackle the issue of embryonic aneuploidy and to assist in the 
identification of euploid embryos by analyzing their chromosome profiles prior 
to transfer. Currently, different biopsy methods can be used to obtain embryonic 
material for genetic analysis, including polar body biopsy of the oocyte, single 
blastomere biopsy of cleavage-stage embryos and TE biopsy of blastocysts. 
Polar body biopsy was shown to be the least efficient way of predicting embryo 
status, as it allows screening for maternal meiotic errors only, without taking 
into account paternally-derived and/or mitotic aneuploidies (Capalbo et al., 
2013; Salvaggio et al., 2014). Blastomere biopsy was long considered to be the 
golden standard for obtaining embryonic DNA for PGT-A, which accounted for 
about 80% of all embryo biopsy methods by the years 2012–2013 (De Rycke et 
al., 2017). However, as mentioned in Chapter 2.3.2., biopsy at earlier stages 
may not be a suitable approach for PGT-A, as high-degree of mosaicism at 
cleavage-stage raises challenges in blastomere analysis and data interpretation; 
hence, blastocyst biopsy became the more preferred option for obtaining 
embryonic material for genetic analysis.  
Although TE biopsy yields good clinical results, it is a rather challenging 
procedure that requires skills and experience of an operator. Following TE 
biopsy, embryos are cryopreserved until the results of genetic testing are 
available. Normally, blastocyst artificial collapse can be performed prior to 
blastocyst vitrification to protect the embryo from ice-crystal formation induced 
membrane damage and improve embryo survival following cryopreservation 
(Chen et al., 2005; Mukaida et al., 2006). During this step, blastocoel fluid can 
be isolated from the embryo by a procedure, termed blastocentesis (Gianaroli et 
al., 2014). The discovery of amplifiable DNA in the blastocoel fluid (BF-DNA) 
made it an object of attention and it was proposed that BF aspiration can be 
used as an alternative less invasive approach for obtaining embryonic material 
for PGT-A. Although the volume of retrieved BF is relatively small, it was 
successfully whole-genome amplified for aneuploidy screening using aCGH 
and NGS (Palini et al., 2013; Zhang et al., 2016). Despite the promises, 
preliminary investigation into BF remained limited and the potential use of BF-
DNA for PGT-A remained questionable, as few of the preliminary studies 
showed contradictive results regarding aneuploidy detection rates and karyo-
typic concordance between BF and different biopsied material derived from the 
same embryo. So far, only one group was able to achieve high concordance rate, 
when comparing genomic profiles of BF with TE cells, polar bodies and 
blastomeres (Gianaroli et al., 2014; Magli et al., 2016). Contrary to this, in other 
reports the discordance in karyotypes reached up to 50% between BF and TE 
biopsy or the rest of whole embryo (Perloe, 2013; Poli et al., 2013; Tobler et al., 
2015). However, previously published studies used aCGH to compare the 
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consistency of diagnosis between BF-DNA and TE biopsies or the rest of the 
whole embryo, so they were not able to investigate the occurrence of embryonic 
mosaicism, which is currently a prominent topic in PGT-A. Therefore, because 
of the inconsistent results and lack of data on blastocyst-stage mosaicism, 
additional studies were warranted to investigate the potential use of BF-DNA 
for diagnostic purposes. Because the scientific world is slowly moving towards 
NGS, and clinical diagnostic laboratories are no exception, in Study III we have 
applied the most widely used commercial NGS-based platform for PGT-A – 
VeriSeq™ PGS (Illumina Inc.) – to simultaneously investigate molecular 
karyotypes of three different embryonic compartments (BF, TE and ICM) 
derived from a single blastocyst. The Veriseq™ platform is reported to reach to 
at least 25 million raw clusters, out of which more than 70% are mapped to the 
genome. With subsequent filtering, approximately 600,000–900,000 reads are 
then used for copy-number calling and the amount of filtered reads is sufficient 
enough to detect mosaic aneuploidies in a biopsied sample with a resolution of 
20–80% (product description was obtained from Illumina Inc). Hence, our study 
design had two advantages over previously published reports: (i) the use of 
high-resolution NGS method with improved sensitivity enabled the detection of 
mosaic chromosomal rearrangements and (ii) the analysis of three different 
embryonic compartments allowed to investigate, to which extent do genomic 
profiles of BF, TE and ICM reflect each other at the blastocyst stage, and to 
evaluate the feasibility of blastocentesis for clinical practice.  
 
 
4.4.1. Proof-of-principle experiments and embryo analysis using NGS 
Before analyzing embryos, we first wanted to check, whether we would be able 
to achieve the same mosaicism detection sensitivity for NGS, as was reported 
recently (Goodrich et al., 2016; Fragouli et al., 2017). To do that, we first 
performed mixing experiments to mimic possible mosaic aneuploidies observed 
in embryos, by previously described approaches (Fragouli et al., 2017; Goodrich 
et al., 2017). Briefly, we obtained fibroblast cell lines with known karyotypes 
from the NIGMS Human Genetic Cell Repository at the Coriell Institute of 
Medical Research (USA). Aneuploid cell lines included trisomy 13 (47,XY,+13; 
GM02948), trisomy 18 (47,XY,+18; GM01359) and trisomy 21 (47,XX,+21; 
GM04616). The proportion of X-chromosome was evaluated by mixing XX cell 
lines with XY. Following culture, individual euploid and aneuploid cells were 
isolated and combined in different ratios, creating a mixture of six cells with 
different proportion of abnormal alleles of interest (0%, 17%, 33%, 50%, 66% 
83% and 100%). Proof-of-principle experiments were performed in three repli-
cates, each time creating new cell mixtures. Subsequently, cell mixtures were 
whole-genome amplified and analyzed via NGS. Internal validation of our 
mixing experiments successfully distinguished mosaic losses and gains that are 
present in at least 20% of cells (Fig. 20), which is concordant to recent 
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comprehensive validation studies on mosaicism detection using next-generation 
sequencing (Goodrich et al., 2016; Fragouli et al., 2017). 
 
Figure 20. Proof-of-principle mixing experiments to evaluate mosaicism detection 
via NGS. Mixing experiments were done in at least three replicates and copy number 
(CN) value was recorded for each event. Geometrical shapes and error bars for each 
chromosome indicate mean and standard deviation of all independent measurements 
[Supplementary Fig. S1 in (Tsuiko et al., 2018)]. 
 
After validation experiments, 16 cryopreserved embryos were then biopsied with 
subsequent amplification of ICM, TE and BF-DNA for NGS analysis. After 
WGA, sufficient amount of DNA was detected in all of ICM and TE samples and 
in 14 out of 16 BF biopsies (87.5%), which is similar to previous reports. 
However, following sequencing and initial quality control, BF chromosome 
profile could not be determined in four embryos. Two embryos also had an 
inconclusive result for either TE or ICM. In total, BF biopsies were compared to 
TE and ICM in 10 out of initial 16 (68.8%) embryos, while the comparison of 
TE and ICM was performed in 14 embryos out of 16 (87.5%). Because low-
grade mosaicism detection within an embryo can be influenced in some degree 
by sampling error and technical artifacts (Munne and Wells, 2017; Treff and 
Franasiak, 2017), we interpreted the findings in embryos according to the 
current Preimplantation Genetic Screening International Society (PGDIS) guide-
lines: embryo, showing mosaicism of <20% were considered to be euploid and 
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>80% were considered as aneuploid embryos with full chromosome losses or 
gains, while all the aneuploidies in the range of 20–80% were classified as 
mosaic. Using these guidelines, aneuploidy screening was performed, with the 
results summarized in Table 2. 
Next, we compared the karyotypes of various biopsy types taken from the 
same embryo and have classified our results as was performed previously 
(Magli et al., 2016): (1) full concordance was reported, when the same 
chromosomes were affected in biopsied samples (including mosaic and/or 
reciprocal losses and gains); (2) partial concordance was reported, when at least 
one chromosome corresponded in both biopsies under comparison, but the 
overall genomic profile did not completely match; and (3) discordance was 
reported, when none of the affected chromosomes in one biopsy corresponded 
to other biopsies. Based on the karyotype, a full chromosome concordance 
between the three embryonic compartments was observed only in four embryos, 
of which three were uniformly euploid and one had a reciprocal mosaic 
aneuploidy (Embryo 1; Table 2). The reciprocal nature of chromosomal 
aberrations indicates that the (mosaic) aneuploidies in the blastocoel DNA are 
not technical artifacts, but rather true biological findings. Similarly, two 
embryos had a monosomy, affecting the same chromosome in all three 
embryonic biopsies, highlighting the meiotic origin of these aneuploidies (Chr 
13 and Chr 7 in Embryo 2 and Embryo 5, respectively; Table 2). We have also 
detected a potentially polyploid embryo with a partially concordant chaotic 
chromosome profile, characterized by multiple reciprocal losses and gains in all 
three embryo compartments [see Fig. 2A in (Tsuiko et al., 2018)]. Chaotic 
genome could be a consequence of chromosome missegregations during first 
post-zygotic cleavages that accumulated throughout the preimplantation 
development, resulting in a likely unviable embryo. The reciprocal mosaic 
aberrations suggest that mitotic errors most likely occurred as a result of 
chromosome non-disjunction, thus corroborating that the DNA obtained from 
blastocoel cavity was of embryonic origin. At the same time, two embryos 
showed multiple aneuploidies in the BF-DNA only, while the corresponding TE 
and ICM had a euploid karyotype [Embryo 4, and Embryo 7 in Table 2; see also 
Fig. 2B in (Tsuiko et al., 2018)].  
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Because of the major differences in the genomic constitution between biopsies, 
it comes as no surprise that the overall number of affected pairs of chromo-
somes (22 pairs of autosomes and one pair of sex chromosomes), including the 
potentially polyploid biopsies, was higher in ten BF samples (79/230), com-
pared to corresponding TE (34/230) or ICM biopsies (26/230) (both P<0.0001, 
Chi-Square test), while no such difference was observed between the available 
14 ICM (27/322) and TE biopsies (35/322) (P = ns). Hence, BF-DNA karyo-
type reached full concordance between either ICM or TE only in 40.0% (4/10) 
of the embryos. In contrast, full concordance between ICM and TE was 
observed in 85.7% (12/14) of the embryos, making TE more representative of 
embryonic chromosomal status than BF (P<0.03). The results of our study are 
similar to previously published report, demonstrating 48% concordance rate 
between BF and ICM-TE (Tobler et al., 2015), but it also drastically contrasts 
with the high concordance rates achieved by another group (Gianaroli et al., 
2014; Magli et al., 2016). Such contradictory outcome may be explained by 
different types of material analyzed and in our case also by a different 
technological approach. The genomic profile of blastocysts may include 
mosaicism that can be missed by aCGH, which is able to detect only high-
degree mosaicism, when >50% of cells are aneuploid (Mamas et al., 2012). 
Here, by using NGS method with improved resolution and sensitivity we were 
also able to determine embryos carrying 20-40% of abnormal cells.  
 
 
4.4.2. Biological and technical challenges associated  
with BF-DNA analysis 
Blastocyst culture has become a milestone in ART and is now widely used for 
selection of viable embryos for transfer. Steadily, day 5 biopsy is also becoming 
the preferred option for obtaining embryonic cells for genetic analysis, 
especially for aneuploidy screening. Apart from the impact of mosaicism on 
embryo development and implantation potential, another major questions still 
lingers in the air: how well does the genomic profile of blastocyst 
trophectoderm layer represent the inner cell mass? The design of our study 
enabled us to explore that question in greater detail, also taking into account the 
mosaic nature of the blastocyst stage. As a major outcome, our data indicates 
that results obtained from BF-DNA may not be comparable to those obtained 
via standard TE biopsies, because BF-DNA does not adequately predict the 
status of the rest of the embryo, while TE is quite representative of ICM and no 
evidence of preferential allocation of aneuploid cells to trophectoderm was 
observed. Of course, a note of caution should be applied here, because unlike in 
clinical practice, where only a small number of cells are analyzed, we have 
screened the whole TE population. Although the impact of BF sampling seems 
less invasive, functional studies on the effect of BF biopsy on embryo viability 
may be warranted, as blastocoel may contain proteins crucial for embryonic 
development (Poli et al., 2015). Thus, contrary to some views that blastocoel 
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biopsy can be a plausible alternative for PGT-A, we argue that blastocentesis as 
a single source of DNA for PGT-A can potentially lead to an increased rate of 
false positive findings, at least using current methods and protocols. For the 
clinic and patients it would mean that a viable embryo with euploid genome can 
be discarded based only on the results of BF-DNA karyotype analysis, making 
it diagnostically unacceptable. One must not forget that PGT-A is also a perfect 
example, where biology compromises technological breakthroughs. The 
presence of embryonic DNA in BF suggests that potential mechanisms might 
exist, by which the genetic material is released into the blastocoel cavity, like 
cell lysis, apoptosis and/or elimination of cellular debris (Hammond et al., 
2016). The intact ICM karyotype in the presence of aneuploidy in BF-DNA in 
some of the embryos also seems to support the idea that aneuploid cells are 
progressively depleted from the developing embryo through apoptosis, ensuring 
the genomic integrity of the future foetus (Bolton et al., 2016). This biological 
phenomenon might also partially explain the high concordance rate previously 
observed between BF-DNA and blastomeres (Magli et al., 2016), as aberrant 
cells may be marginalized into the blastocoel cavity at later stages of 
development, releasing their genetic material that is later picked up again during 
BF analysis. DNA in blastocoel fluid might also be prone to fragmentation/ 
degradation and combination of these factors results in chaotic chromosome 
profiles of BF samples. In turn, this would also have a direct clinical 
consequence, because when evaluating BF-DNA, one might look at the 
genomes of cells that were discarded by the embryo, without knowing the real 
status of ICM. However, given the remarkable genomic plasticity of early 
embryogenesis, the true origin of genetic material in blastocoel cavity awaits 
elucidation and advanced genome-wide haplotyping technologies might shed 
some light on this matter. Taken together, the biology behind BF-DNA data 
interpretation must be adequately elucidated before implementing it as a 
diagnostic tool in everyday clinical practice. 
In addition to biological challenges, technical limitations can also prevent 
the use blastocentesis as a first choice biopsy method. Any micromanipulations 
during BF aspiration can also potentially alter the downstream applications, and 
in our case aspiration of BF after embryo vitrification and thawing might have 
potentially interfered with obtaining good quality data. Still, it is important to 
note that blastocoel fluid contains cell-free DNA with similar profile of 
fragmented cell-free DNA found in human plasma (Zhang et al., 2016), the 
quantity and quality of which may also vary from embryo to embryo. It is well 
established that low amount of good quality DNA may be prone to uneven 
amplification and allele drop-out (Huang et al., 2015) and subsequent library 
preparation methods and technical artifacts can result in an altered 
representation of the genome that will reduce the reliability of chromosome 
analysis (Goodrich et al., 2016). The overall increased noise ratio can also inter-
fere with low-grade mosaicism evaluation. In the end, the diagnostic accuracy 
will suffer and the use of BF-DNA as a source of DNA for embryo screening 
might become restricted (at least using current methods and protocols). Notably, 
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our data indicates that TE and ICM genomic profiles showed either lower level 
of mosaicism or absent aneuploidy, compared to corresponding BF-DNA 
profiles, so one might argue that from the clinical and diagnostic point of view 
the use of insensitive to mosaicism aCGH platform (that detects only >50% 
mosaicism) might seem like a more suitable approach for the analysis of BF-
DNA, because the potentially biologically irrelevant low-grade mosaicism in 
BF would not be detected. On the other hand, embryos with normal TE and 
ICM karyotype also showed high-grade mosaic aneuploidies in BF that would 
likely be interpreted as true finding using aCGH, leading to misdiagnosis. Such 
discordance was also reported previously (Perloe, 2013; Poli et al., 2013; Tobler 
et al., 2015) and taking into account BF-DNA features, none of the methods 
seem to have any major advantages or disadvantages. In contrast, because 
karyotype concordance were much higher in TE and ICM cells, it seems that 
chromosome analysis of TE biopsy remains a more optimal and effective way 
for predicting the karyotype of an embryo. However, more comprehensive 
studies on embryonic mosaicism are warranted that would help refine the 
criteria for embryo selection for transfer without compromising the treatment 
success rate by excluding mosaic embryo capable of forming viable 
pregnancies. 
 
 
4.5. Future perspectives  
Over the last decade single-cell technologies paved way to many breakthrough 
discoveries in the field of reproductive genetics, but as it goes in science, 
providing an answer to one question only leads to more questions. Because 
embryonic aneuploidy is not restricted only to human, but can exist also in other 
mammalian species, in our Study I we first aimed to understand the prevalence 
of chromosomal imbalances in cattle and to compare it to human. Although 
chromosomal instability is common in both human and bovine in vitro 
cleavage-stage embryos, as demonstrated by the results, cellular and molecular 
mechanisms driving this error-prone stage of development are still poorly 
described. The fact that aberrant cells can persist as far as blastocyst stage 
suggests that embryos may possess unique cellular regulatory mechanisms that 
make them more vulnerable to chromosome segregation errors. First, studies on 
mouse and porcine embryos suggest that DNA damage checkpoint and repair 
may be insufficient in embryos prior to EGA due to limited ATM kinase 
activity, which is the major upstream mediator of the DNA damage response 
and repair pathway (Adiga et al., 2007; Wang et al., 2015). The loss of ATM 
activity in early mouse embryos and embryonic stem cells compromises 
phosphorylation of downstream targets necessary for the repair of DNA double-
strand breaks, consequently leading to proliferation defects and genomic 
instability due to chromatid breaks (Yamamoto et al., 2012). Second, upon 
massive DNA damage somatic cells triggers apoptosis to eliminate the damaged 
cells, however functional apoptotic pathways seem to be suppressed in early 
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human and bovine cleavage-stage embryos to facilitate embryo survival until 
later stages of development (Fear and Hansen, 2011; Bazrgar et al., 2014). 
Finally, embryonic cell cycle checkpoints and regulators may be more 
permissive to chromosome missegregations, allowing rapid cleavage divisions. 
Indeed, some of the essential G1 and G2 cell checkpoint proteins, like RB and 
WEE1, are silenced in 8-cell human embryos and are only activated at later 
stages of development (Kiessling et al., 2009; Kiessling, 2010; Kiessling et al., 
2010). Taken together, these observations suggest that, unlike somatic cells, 
blastomeres with damaged or incompletely replicated DNA and/or improper 
chromosome alignment can still proceed to mitosis, bypass SAC-mediated 
arrest and apoptosis, and continue cell division, leading to increased rates of 
chromosomal aberrations and aneuploidy upon post-zygotic divisions. 
Intriguingly, late embryonic genome activation may trigger apoptotic response 
in the embryo to eliminate aneuploid cells from further development, so even 
mosaic embryos can still result in live birth, challenging the hypothesis that 
aneuploid embryos are developmentally incompetent. In turn, this raises 
important questions regarding the burden and nature of genomic imbalances that 
can be tolerated by the embryo without compromising its survival. With this in 
mind, further research also needs to address the putative role of CIN in 
subsequent post-implantation and prenatal development to understand, which 
genomic anomalies can be compatible with normal foetal development.  
As a major breakthrough of Study I, we have incidentally discovered that 
zygotes can spontaneously segregate entire parental genomes to distinct cellular 
lineages, following first cytokinesis. The discovery of this phenomenon, termed 
heterogoneic division, was possible due to the use of a novel computational 
method, enabling concurrent genome-wide haplotyping and copy number 
profiling of single-cells. Importantly, heterogoneic cell lineages were observed 
not only in dispermic embryos, but such event can also spontaneously arise 
from normally fertilized zygotes. These findings provide novel conceptual 
framework for the emergence of embryonic mixoploidy that may also poten-
tially underlie the pathogenesis of gestational trophoblast diseases (GTD) – rare 
pregnancy-related disorders, characterized by the abnormal tissue growth inside 
a woman’s uterus. For example, complete hydatidiform moles (CHMs) of 
androgenetic origin is the most common form of GTD that occurs in human in 
about 1 in every 1500 pregnancies (Moein-Vaziri et al., 2018). In human CHMs, 
the foetus and amniotic membranes are usually absent and the product of 
conception resembles a grape-like structure that can become invasive, deve-
loping into malignant trophoblastic cancer, known as choriocarcinoma. CHMs 
have also been reported in bovine with tissue structures similar to human, but 
the exact aetiology of bovine hydatidiform moles is unclear (Meinecke et al., 
2002; Morris et al., 2008). The current dogma states that the origin of CHMs 
comes from fertilization of an anuclear egg by a haploid sperm with subsequent 
endoreplication (Jacobs et al., 1980). Another hypothesis states that CHMs are a 
result of premature independent mitotic division of a male haploid pronucleus 
with subsequent fusion (diploidization) of these two post-mitotic products and 
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disappearance of the egg pronucleus (Golubovsky, 2003). It is not clear why 
and how the female pronucleus would be eliminated. Hence, the observed 
persistence and independent proliferation of distinct androgenetic and gyno-
genetic cell lineages in our study may provide a novel and more plausible 
mechanistic basis for the formation of some types of GTDs. Due to high 
proliferative capacity, these distinct cell lineages can outgrow other blastomeres 
and upon implantation such embryo can potentially give rise to abnormal 
pregnancy formation. However, the frequency of this phenomenon, as well as 
fate of mixoploid embryos remains to be investigated. In addition, the existence 
of heterogoneic cell division in zygotes prompts an investigation into the regu-
latory mechanisms of cell divisions during preimplantation embryo develop-
ment. Different pathways have been proposed recently, as to how and why the 
symmetric propagation of parental genomes during embryonic development 
would get perturbed, and these hypothesis include the formation of a gonomeric 
spindle driven by asymmetric k-MT dynamics between parental genomes and 
asynchronous parental cell cycles in the zygote, driving the nucleation of 
parental-specific “private” spindles (Destouni and Vermeesch, 2017). Recently, 
an elegant microscopy study in mice has demonstrated that during the first post-
zygotic division, male and female chromosomes are assembled on separate 
mitotic spindles, challenging the old model of nuclear envelope breakdown 
(Reichmann et al., 2018). Hence, failure to properly align two zygotic spindles 
would provide a mechanistic basis for parental genome segregation. Further 
fundamental research in the field of cellular biology combined with confocal 
live-cell imaging technologies will greatly contribute to our understanding of 
zygotic chromatin, kinetochore and spindle dynamics that underlie successful 
maternal-to-zygotic transition.  
Because maternal factors regulate first zygotic and post-zygotic processes, it 
is important to expand our knowledge on molecular mechanisms of oocyte 
nuclear and cytoplasmic maturation and determine factors that influence oocyte 
competence. In human IVF, it is relatively hard to acquire oocytes for research. 
Instead, easily accessible granulosa/cumulus cells can shed some light on the 
biology of the oocyte, because they shape its intrinsic parameters during 
oogenesis, therefore they can potentially reflect the characteristics of the oocyte 
and future embryo. Indeed, altered gene expression in granulosa cells was asso-
ciated with oocyte aneuploidy (Fragouli et al., 2012), so it was hypothesized 
that impaired somatic cell function and altered follicular microenvironment can 
lead to reduced oocyte and embryo quality. Transcriptome profiling of cumulus 
and granulosa cells has also been investigated as a novel non-invasive approach 
to evaluate oocyte and embryo quality (Uyar et al., 2013), but the practicality of 
this type of testing was questioned recently (Green et al., 2018). Still, the 
information on how cumulus cells determine or reflect oocyte and embryo 
quality is scarce and detailed characterization of molecular transcriptome 
profiles of cumulus cells in relation to oocyte and embryonic aneuploidy awaits 
further investigation. From translational point of view, oocyte and granulosa/ 
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cumulus cells-targeted research might potentially be quite beneficial in the 
development of IVM protocols.  
In light of our research, it is also important to understand how in vitro 
conditions influence oocytes and early embryo development. Ultimately, IVF 
embryos must survive a rough artificial environment very different to that in 
natural reproduction. In our Study II, we compared the genomic architecture of 
in vivo and in vitro bovine embryos and we have demonstrated the negative 
impact of in vitro conditions on genomic stability of early bovine embryos. 
Another profound aspect of IVF that deserves further investigation is the 
potential influence of in vitro culture systems on embryonic epigenome. During 
early embryogenesis major epigenetic reprogramming takes place that is 
essential for proper embryo development, but this process can be vulnerable to 
in vitro techniques and culture environment. These effects have mostly been 
studied in bovine, where calves born from in vitro produced embryos often 
exhibit increased birth weight, known as large offspring syndrome, which is 
similar to Beckwith-Wiedemann syndrome in human (Chen et al., 2015; Sirard, 
2017). Altered phenotype observed in these calves was likely the result of 
failure to properly establish or maintain DNA methylation levels in early 
embryogenesis. The regulation of embryonic epigenome may also pose safety 
concerns regarding IVF, because of the worry that it might have detrimental 
long-term health consequences in IVF newborns (Pinborg et al., 2015; Ventura-
Junca et al., 2015; Jiang et al., 2017). In the future, the upcoming sophisticated 
single-cell multiomics approaches, which allow screening both the (epi)genome 
and transcriptome of a single cell, can fill in the missing gaps on the regulation 
of preimplantation development and pinpoint to essential biological pathways, 
dysfunction of which can also predispose the embryo to aneuploidy. In addition, 
with the translation of the uterine lavage technique (which has been used in 
cattle for over 40 years) to human (Pagidas et al., 2014), the ability to analyse 
naturally conceived human embryos will soon become a reality. The obtained 
knowledge on the molecular control of oocyte maturation that determines 
subsequent embryonic developmental potential, as well as IVF factors that 
compromise embryonic survival will help to refine and improve assisted 
reproductive technologies and in vitro culture conditions in human.  
Finally, nowadays, numerous attempts are made to find the best way to 
predict embryo aneuploidy, including blastocoel fluid biopsy and evaluation of 
embryo spent culture medium. In Study III, we have analysed the genomic 
profiles of blastocoel fluid and showed that BF-DNA demonstrated low con-
cordance rates with TE and ICM of an embryo. This result is in line with some 
of the previously published reports, suggesting that due to dynamic nature of 
early embryogenesis, indirect embryo testing, in which the embryonic genome 
is not analyzed directly from the embryonic cells, is not yet a reliable approach 
for diagnostic purposes. Notably, in recent years, the increasingly popular PGT-
A has created a predominant view that only genetically normal embryos are 
required to attain pregnancy. However, we can also look at CIN from a different 
angle that completely differs from the black-and-white clinical perspective: the 
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evolutionary angle. Chromosomal mutations may, albeit rarely, provide 
unexpected evolutionary advantage to an organism [reviewed in (Carbone and 
Chavez, 2015)]. Intriguingly, many inversions, translocations and centric 
fissions, which drive genome evolution, can already take their origin during 
cleavage-stage of development. Although the elevated levels of genomic 
aberrations in oocytes and IVF embryos are most likely a by-product of adverse 
in vitro conditions and manipulations, both in vitro and in vivo embryo genome 
dynamics can underlie mosaicism, chimerism and mixoploidy in live-born 
individuals. Hence, one might speculate that chromosomal rearrangements in 
natural conception may also potentially drive the evolution by speciation (e.g. 
the formation of new and distinct species in the course of evolution), as 
extensive chromosomal rearrangements distinguish the karyotype of more 
distant relatives. In addition, transposable elements, activation of which can 
occur already during preimplantation development (Gerdes et al., 2016), are at 
the core of genetic transformation, establishing novel transcriptional and species-
specific gene regulatory network by disrupting genome integrity (Chuong et al., 
2017). Unfortunately, the full extent of aneuploidy and CIN in human oocytes 
and embryos in natural conception is not currently known. Nevertheless, the 
possible elevated rate of CIN in human early reproduction and its potential role 
in genome evolution itself may potentially be an intriguing topic for 
evolutionary biologists that awaits to be discussed, at least at a theoretical level.  
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CONCLUSIONS 
The uprising era of single-cell research has expanded our knowledge on early 
embryogenesis, highlighting the alarming fact that cleavage-stage embryos have 
high prevalence of chromosomal instability (CIN), which represents one of the 
most serious challenges in IVF. The current thesis addresses the topic of CIN in 
early embryos, focusing on important fundamental and translational questions:  
1. Embryo-related research is ethically one of the most complex areas of 
reproductive science that greatly relies on the use of appropriate animal models, 
so the first aim of the thesis was to investigate the genomic profile of bovine in 
vitro cleavage-stage embryos. By using novel single-cell genomics approaches, 
the current thesis demonstrates that the nature and frequency of genomic 
abnormalities in in vitro cleavage-stage embryos is highly conserved between 
cattle and human, making bovine embryo a suitable model for elucidating the 
origins and molecular mechanisms of CIN in early preimplantation develop-
ment.  
2. The second aim of the thesis was to evaluate the nature and prevalence of 
CIN in naturally conceived embryos, in comparison to in vitro embryos. By 
using the established bovine model the current thesis demonstrates that oocyte/ 
embryo micromanipulations and in vitro culture exacerbate CIN in early 
cleavage-stage bovine embryos, compromising their survival rate. If this is the 
same for human, then in vitro environment can greatly reduce the number of 
viable embryos for transfer. In turn, this should encourage scientific and medical 
communities not only to refine and improve in vitro culture conditions, but also 
raise awareness on fertility issues among men and women of reproductive age. 
3. Based on the unexpected results of bovine single blastomere analysis, the 
current thesis also demonstrates that zygotes can segregate entire parental 
genomes into separate blastomeres, creating androgenetic and gynogenetic cell 
lineages. Intriguingly, it seems that in vivo embryos may also undergo hetero-
goneic division, suggesting that parental genome segregation can happen 
regardless of in vitro or in vivo environment. This observation opens up new 
horizons into investigating the mechanistic origin of mixoploidy and 
chimaerism in humans. 
4. The final third aim of the study was to investigate the utility of blastocoel 
fluid analysis for preimplantation genetic testing for aneuploidy (PGT-A). The 
use of blastocoel fluid biopsy, or blastocentesis, for PGT-A has gained much 
controversial attention. The data presented in the current thesis demonstrates 
that DNA from blastocoel fluid can be successfully amplified and sequenced, 
but due to biological and technical challenges, as well as increased discordance 
rate between inner cell mass and trophectoderm, blastocentesis is not suitable 
for diagnostic purposes, at least using current protocols and methods. Therefore, 
trophectoderm biopsy remains the safest option with the most reliable results for 
comprehensive chromosome screening. 
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In summary, the current thesis raises scientific excellence and brings new and 
unique knowledge on genomic instability in mammalian embryos. The novel 
insight obtained here opens up new conceptual frameworks to study important 
questions on the origin and fate of embryonic CIN. The data demonstrated here 
is also critical for reproductive medicine and raises the need to revise IVF as we 
know it. However, one must always remember that although the use of animal 
models is sometimes inevitable due to ethical reasons, caution must be applied 
when extrapolating animal data to humans.  
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SUMMARY IN ESTONIAN 
Kromosomaalne ebastabiilsus imetajate varajastes embrüotes 
Viljatus on kogu maailmas kiiresti kasvavaks probleemiks ning iga kuues paar 
seisab silmitsi olukorraga, et soovitud rasedust ei teki. Esmasünnitajate kesk-
mine vanus kasvab samuti, kuid naise vananedes tema viljakus langeb ning see-
tõttu pöördub tänapäeval aina rohkem paare viljatusravi poole, et leida oma 
probleemile lahendus. Kehaväline viljastamine (in vitro fertilization, IVF), mille 
korral toimub munarakkude viljastamine ning embrüote areng katseklaasis, on 
maailmas kõige sagedamini kasutatav lastetusravi meetod. IVF protseduuri 
tulemusena sünnib Eestis rohkem kui 600 last aastas, mis moodustab 4–5% 
kõikidest vastsündinutest. Samas annab IVF ravi erakordse võimaluse ana-
lüüsida inimese varajase embrüo arengut väljaspool naise organismi. Viimastel 
aastatel on üksikraku tehnoloogiate areng laiendanud meie teadmisi varajase 
embrüogeneesi osas. Embrüote üksikute blastomeeride genoomi uuringud on 
näidanud, et varajaste embrüote tähelepanuväärseks iseärasuseks on väga sage-
dased kromosomaalsed aberratsioonid, mis võivad esineda kuni 80% emb-
rüotes. Paraku on embrüo aneuploidsus kõige suurem väljakutse IVF ravil, sest 
see on üks peamisi raseduse varajase katkemise (kuni 75%) ja IVF ebaõnnestu-
mise põhjuseid. See on ajendanud teadlasi uurima nii embrüo kromosoomide 
aberratsioonide tekkemehhanisme, kui ka nende esinemissagedust mõjutavaid 
faktoreid. Paralleelselt sellele on hakanud märgatavalt parenema ka embrüo 
diagnostilised meetodid, mis aitavad hinnata IVF protseduuril saadud embrüote 
eluvõimelisust, tuvastada pärilikke haigusi põhjustavaid geenialleele ja kromo-
soomi muutusi embrüotes ning võimaldavad selekteerida geneetiliselt „terveid“ 
embrüoid emakasse siirdamiseks. Käesoleva doktoritöö eesmärgiks oli kaas-
aegseid üksikraku genoomi tehnoloogiaid kasutades uurida embrüote genoomi 
ebastabiilsust, keskendudes olulistele fundamentaalsetele ja rakenduslikele 
küsimustele:  
1. Embrüotega seotud teadustöö on väga piiratud eetiliste põhjuste tõttu, 
seega sõltuvad inimese embrüote uuringud suurel määral sobivatest loom-
mudelitest. Kasutades uudset üksikraku kogu-genoomi analüüsi metoodikat, 
näidati antud doktoritöös, et ka veise IVF embrüotes esinevad väga sagedased 
kromosomaalsed aberratsioonid, mille tulemusena on suurem osa varajasi 
embrüoid mosaiiksed. Seega on veis hea mudel inimese embrüogeneesi uuri-
miseks ning genoomi ebastabiilsuse päritolu selgitamiseks varajases preimplan-
tatsioonilises arengufaasis.  
2. Bioloogia fundamentaalne dogma ütleb, et raku jagunemisel saavad mõle-
mad tütarrakud kaks genoomi koopiat: üks pärineb isalt ja üks emalt. Käes-
olevas doktoritöös näidati embrüo genoomi erakordset plastilisust, mis lükkab 
antud dogma ümber. Nimelt avastati genoomi ebastabiilsuse uuringute käigus, 
et embrüo on võimeline segregeerima ema- ja isapoolse genoomi eraldi raku-
liinidesse. Selline unikaalne nähtus avastati tänu kogu-genoomi DNA analüüsi 
metoodikale, mis võimaldab samaaegselt määrata nii haplotüüpe, kui koopia-
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arvu muutusi üksikutes rakkudes. Tuvastatud heterogoneeiline (heterogoneic, 
kreeka keeles „erinev vanemate päritolu“) sügoodi jagunemine avab uusi 
teadussuundi, et uurida varajaste preimplantatsiooni embrüote raku jagunemise 
regulatoorseid mehhanisme. Samuti võib heterogoneeiline sügoodi jagunemine 
olla aluseks eriploidsuse (mixoploidy) ja kimääride tekkele, kuid selle nähtuse 
esinemissagedus on hetkel teadmata.  
3. Kromosoomide aneuploidsus on iseloomulik inimese IVF embrüotele, 
kuid arvatakse, et kromosomaalne ebastabiilsus ei piirdu ainult in vitro 
embrüotega vaid esineb ka in vivo embrüotes. Sellist hüpoteesi toetab ka 
asjaolu, et embrüote aneuploidsus on peamine raseduse varajase katkemise 
põhjus. Lisaks sellele on kirjanduses avaldatud andmeid harva esinevate 
juhtumite kohta, kus indiviidil on tuvastatud eriploidne ja/või mosaiikne karüo-
tüüp. Kasutades veise loommudelit, näidati käesolevas doktoritöös, et kromo-
somaalne ebastabiilsus eksisteerib samuti loomulikul teel saadud embrüotes 
ning ka in vivo embrüod võivad segregeeruda vanemata genoomi, mis viitab 
sellele, et see protsess toimub sõltumata in vivo või in vitro keskkonnast. 
Heterogoneeiline jagunemine in vivo embrüotes võib seletada eriploidsuse 
esinemist looduses. Samas suurendab munarakkude ja embrüote in vitro mani-
puleerimine kromosomaalse ebastabiilsuse sagedust veise varajastes embrüotes, 
vähendades nende elujõulisust. Kui sama trend kehtib ka inimese embrüote 
puhul, tähendab see, et in vitro keskkond võib drastiliselt kahandada „tervete“ 
embrüote arvu emakasse siirdamiseks, sest embrüod peavad ellu jääma karmis 
kunstlikus keskkonnas, mis erineb suurel määral loomulikest tingimustest. 
Omakorda peaks see julgustama teadus- ja meditsiinikogukonda mitte ainult 
parandama in vitro kultuuri tingimusi, vaid ka tõstma reproduktiivses eas 
olevate inimeste teadlikkust viljakuse ja IVF ravi osas.  
4. Tänapäeval kasutatakse preimplantatiivses embrüo sõeluuringus (PGT-A) 
kas kolmanda päeva biopsiat (analüüsitakse ühte embrüo rakku) või viienda 
päeva biopsiat (analüüsitakse 5–6 rakku). Viimasel ajal on aga hakatud pöörama 
suuremat tähelepanu ka blastotsööli vedeliku (blastotsüsti sees olev vedelik) 
analüüsile, kuid selle analüüsi tulemused on olnud seni vastuolulised. Käesoleva 
doktoritöö raames analüüsiti viienda päeva embrüoid, millest oli eraldatud kolm 
erinevat blastotsüsti osa: sisemine rakumass (inner cell mass, ICM), trofekto-
dermi rakud ning blastotsööli vedelik. Tulemuste analüüsil selgus, et blasto-
tsööli vedelik ei peegelda alati kromosoomide olukorda ICM-s või trofekto-
dermi rakkudes ning seda meetodit ei saa hetkel kasutada embrüote kromo-
soomide analüüsis.  
 
Kokkuvõttes annab käesolev doktoritöö uut ja praktilist informatsiooni emb-
rüote genoomi ebastabiilsuse kohta. Antud töö püstitab samuti olulisi küsimusi 
embrüo arengut mõjutavate molekulaarsete faktorite kohta, mis väärivad 
edaspidist uurimist ja tähelepanu. Antud teadmisi saab tulevikus rakendada 
reproduktiivmeditsiinis, mis on paljudele peredele ainukeseks võimaluseks 
saada järglasi.  
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and Natalie S., Kris and Hilde. A very big thank you also goes to Veerle 
Mattheus, Annemie Puttemans and Narcisse Opdekamp for administrative 
support and for making sure that things run smoothly and according to the rules.  
All this incredible cow work was a true effort of prof. Ann Van Soom’s 
group, including Katrien and Maaike, so thank you for this heroic act! Maaike – 
keeping up with those cows that throw poop at you – it is a work of blood, 
sweat and tears! Too bad we could not get our cows for BBQ. By the way, 
thanks for not leaving me behind when I ran into trouble with the security 
during terrorist threat level 4; from that moment I knew we are a real team! 
Good luck at your new job, boss lady!  
Big thanks also goes to prof. Thierry Voet and the amazing people of his lab: 
Niels, Koen, Parveen, Masoud, Elia, Daniel (with Justine and her cakes on the 
side) and the rest of the group for pushing the boundaries of single-cell 
technologies to a whole new level. Of course, all the credit for computational 
work goes to Masoud – thanks for putting on our detective hats during sample 
mix-ups and unexpected inbreeding (you can’t fool genetics). Parveen – thanks 
for our spontaneous drinks and random conversations, they were one of a kind! 
After you left, the dynamics were never the same, but luckily I still had my 
Fresita! Elia, I might have finally earned a badge of my own, but I will always 
raccoon food from you, just so you know. Thanks for all the “fresh” air breaks 
and no-drama moments.  
A very special place in my acknowledgments goes to my favorite people in 
the world: Tanya, Romain and Kurt. Tanya – you are the best colleague one can 
wish for and an even better friend! You are always there to help people, putting 
their needs ahead of yours. Even when your own deadlines pressure you, you 
still find time to make a graph for someone or check their documents! Thanks 
for all the support and encouragements throughout the years and for all the 
crazy adventures. Meow! Romain and Kurt – unfortunately I cannot make 
inappropriate jokes, so I will have to keep it boring. It was much harder for 
me to leave home for the second time to return back to Belgium (just to lock 
myself out of the apartment), but you made it so easy, by turning my frown 
upside down (or maybe it was just the effect of G&T, masterly prepared by 
Kurt). Wednesday is my favorite day, because I know I will be standing in my 
little kitchen corner, occasionally peeling and cutting and chopping (herb lady 
as I am). Thank you for your friendship and hospitality and for always making 
me feel at home. Go Estolgium!  
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Дорогие родители!  
Этот долгий путь наконец-то достиг конца, и весь этот непонятный тезис с 
набором английских слов посвящён вам! Спасибо за вашу нескончаемую 
поддержку и веру, а самое главное – за доверие. Дорогая мама, я уехала в 
Бельгию с самым тяжёлым сердцем, но ты доказала, что можно 
преодолеть все жизненные барьеры, главное не сдаваться! Твой дух и твоя 
стойкость были моими самыми большими источниками сил. Дорогой 
папа – спасибо, что был нашим главным телемостом, который помогал 
держать связь (а то мама за компьютером… ), и, конечно же, Шмель – 
спасибо, что на протяжении университетских дней всегда катал меня с 
поезда на поезд в любое время суток.  
Дорогой Злат – пусть эта книга служит тебе примером, что нам всё по 
зубам, главное захотеть и работать в нужном направлении! Кто сказал, что 
мы хуже, чем супергерои?   
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